/artkey/inf-999912-0001_Pokyny_pro_autory_prispevku_do_casopisu_Onkologie.php weekly 0.3 /artkey/inf-999912-0002_Onkologie.php weekly 0.3 /artkey/inf-999912-0010_Inzerce.php weekly 0.3 /artkey/inf-999912-0011_Kontakty.php weekly 0.3 /artkey/inf-888800-0003_Predstaveni_spolecnosti_Solen.php weekly 0.3 /artkey/inf-888800-0005_redakcni_prace.php weekly 0.3 /artkey/inf-888800-0006_Odborne_akce_na_8222_klic_8220_-_komplexni_servis.php weekly 0.3 /artkey/inf-888800-0007_Graficke_a_tiskove_prace.php weekly 0.3 /artkey/inf-999912-0021_Instructions_for_authors.php weekly 0.3 /artkey/inf-999912-0022_About.php weekly 0.3 /artkey/inf-999912-0023_Editorial_board.php weekly 0.3 /artkey/inf-999912-0031_Contacts.php weekly 0.3 /artkey/inf-990000-2300_Publikacni_etika.php weekly 0.3 /artkey/inf-990000-2400_Publication_ethics.php weekly 0.3 /artkey/inf-999912-0032_Objednavka_casopisu.php weekly 0.3 /artkey/inf-990000-9400_Solen_-_About_Us.php weekly 0.3 /artkey/inf-990000-9500_Educational_Events.php weekly 0.3 /artkey/inf-990000-9700_Kontakty.php weekly 0.3 /artkey/inf-990001-0100_Nabidka_sluzeb.php weekly 0.3 /artkey/inf-990001-0200_Odpovedna_firma.php weekly 0.3 /artkey/inf-990001-7800_Reference.php weekly 0.3 /artkey/inz-990000-0200_Vlozit_inzerat.php weekly 0.3 /artkey/inz-990000-0300_Zakladni_informace.php weekly 0.3 /artkey/inz-990000-0400_Kontakty.php weekly 0.3 revartsetting.php weekly 0.3 /aktualni-akce.php?mag=xon weekly 0.3 /rolrequest.php weekly 0.3 /personalni-inzerce weekly 0.3 / weekly 0.3 /casopisy.php weekly 0.3 /magorder.php weekly 0.3 /akce-na-klic.php weekly 0.3 /current_issue.php daily 0.7 /archive.php daily 0.7 /magno/xon/2026/mn1.php daily 0.7 /artkey/xon-202601-0013_terapie_melanomu_8211_quo_vadis.php daily 0.7 /artkey/xon-202601-0004_cilena_terapie_akutni_myeloidni_leukemie_ivosidenib_u_pacientu_s_mutaci_idh1.php daily 0.7 /artkey/xon-202601-0005_nova_nadeje_pro_pacienty_s_metastatickym_nsclc_a_egfr_mutaci.php daily 0.7 /artkey/xon-202601-0006_nemelanomove_kozni_nadory_soucasne_poznatky_o_diagnostice_prevenci_a_lecbe.php daily 0.7 /artkey/xon-202601-0007_kompletni_remise_lokoregionalne_pokrocileho_msi-h_karcinomu_rekta_pri_imunoterapii.php daily 0.7 /artkey/xon-202601-0008_dlouhodobe_preziti_pacientky_s_metastatickym_karcinomem_slinivky_brisni_lecene_ve_2_linii_rezimem_nal-iri_a_5-.php daily 0.7 /artkey/xon-202601-0009_trifluridin_tipiracil_v_kombinaci_s_bevacizumabem_v_lecbe_metastatickeho_adenokarcinomu_urachu_-_literarni_revi.php daily 0.7 /artkey/xon-202601-0010_varianty_v_gene_braf_v_melanomoch_koze.php daily 0.7 /artkey/xon-202601-0012_novinky_z_asco_american_society_of_clinical_oncology_gi_2026.php daily 0.7 /artkey/xon-202601-0001_nove_trendy_v_imunoterapii_melanomu.php daily 0.7 /artkey/xon-202601-0002_zmena_kombinace_braf_a_mek_inhibitoru_jako_cesta_k_dlouhodobe_stabilizaci_metastazujiciho_melanomu.php daily 0.7 /artkey/xon-202601-0003_fixni_kombinace_nivolumabu_a_relatlimabu_v_lecbe_metastazujiciho_melanomu_zvladnuti_muskuloskeletalni_toxicity.php daily 0.7 /artkey/xon-202601-0011_vyznam_pohybove_aktivity_u_onkologickych_pacientu.php daily 0.7 /magno/xon/2025/mn1.php weekly 0.7 /flashbook/xon/2025/1.php monthly 0.2 /artkey/xon-202501-0015_intersticialni_brachyterapie.php weekly 0.7 /artkey/xon-202501-0007_terapie_kras_pozitivniho_metastatickeho_nemalobunecneho_plicniho_karcinomu_ve_druhe_linii_lecby.php weekly 0.7 /artkey/xon-202501-0008_moznosti_lecby_kras_g12c_mutovaneho_metastatickeho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-202501-0009_kazuistika_pacienta_s_dlouhodobym_efektem_trifludin_tipiracilu.php weekly 0.7 /artkey/xon-202501-0010_pleomorfny_dermalny_sarkom.php weekly 0.7 /artkey/xon-202501-0001_intersticialni_brachyterapie_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-202501-0002_intersticialni_hdr_brachyterapie_nadoru_penisu.php weekly 0.7 /artkey/xon-202501-0003_akcelerovana_parcialni_radioterapie_casneho_karcinomu_prsu_pomoci_perioperacni_intersticialni_hdr_brachyterapie.php weekly 0.7 /artkey/xon-202501-0004_fyzikalni_aspekty_planovani_hdr_intersticialni_brachyterapie.php weekly 0.7 /artkey/xon-202501-0005_pece_o_pacienty_podstupujici_intersticialni_brachyterapii_z_pohledu_sestry.php weekly 0.7 /artkey/xon-202501-0006_intersticialni_brachyterapie_v_komplexni_lecbe_karcinomu_hrdla_delohy.php weekly 0.7 /artkey/xon-202501-0011_strategie_zvladani_zateze_v_obdobi_lecby_a_rekonvalescence_u_onkologickych_pacientu_zapojenych_do_pacientskych.php weekly 0.7 /artkey/xon-202501-0012_imunoonkologicka_lecba_nsclc_napric_stadii.php weekly 0.7 /artkey/xon-202501-0013_nove_moznosti_tercove_lecby_v_kombinaci_s_chemoterapii.php weekly 0.7 /artkey/xon-202501-0014_trastuzumab_deruxtecan_u_pacientu_s_predlecenym_metastatickym_nemalobunecnym_karcinomem_plic_s_her2_erbb2_mut.php weekly 0.7 /magno/xon/2025/mn2.php weekly 0.7 /artkey/xon-202502-0009_pokroky_v_lecbe_urotelialniho_karcinomu_nove_horizonty_a_vyzvy.php weekly 0.7 /artkey/xon-202502-0005_zilni_vstupy_v_onkologii_-_volba_mezi_picc_a_portem.php weekly 0.7 /artkey/xon-202502-0006_pacientka_s_metastazujicim_sliznicnim_melanomem_anorekta.php weekly 0.7 /artkey/xon-202502-0007_kompletni_remise_generalizovaneho_dlazdicobunecneho_karcinomu_jicnu.php weekly 0.7 /artkey/xon-202502-0008_manazment_epiteloidneho_inflamatorneho_myofibroblastickeho_sarkomu_plucneho_p_vodu.php weekly 0.7 /artkey/xon-202502-0001_soucasne_moznosti_adjuvantni_lecby_urotelialnich_karcinomu.php weekly 0.7 /artkey/xon-202502-0002_role_imunoterapie_v_lecbe_metastatickeho_urotelialniho_karcinomu.php weekly 0.7 /artkey/xon-202502-0003_neoadjuvantni_terapie_karcinomu_mocoveho_mechyre.php weekly 0.7 /artkey/xon-202502-0004_radioterapie_jako_organ_zachovny_postup_v_lecbe_invazivniho_karcinomu_mocoveho_mechyre.php weekly 0.7 /magno/xon/2025/mn3.php weekly 0.7 /artkey/xon-202503-0011_paliativni_medicina_jako_soucast_moderni_onkologie.php weekly 0.7 /artkey/xon-202503-0005_febrilni_neutropenie.php weekly 0.7 /artkey/xon-202503-0006_vitamin_d_a_jeho_klinicke_vyuziti.php weekly 0.7 /artkey/xon-202503-0007_rastuca_vyzva_maligneho_melanomu_strategie_pre_zlepsenie_starostlivosti.php weekly 0.7 /artkey/xon-202503-0009_kozne_metastazy_karcinomov_pochadzajucich_z_visceralnych_organov_-_prispevok_k_problematike_a_opis_pripadov_z_p.php weekly 0.7 /artkey/xon-202503-0010_kompenzace_preruseni_radioterapie_u_pacienta_s_karcinomem_orofaryngu.php weekly 0.7 /artkey/xon-202503-0004_ohlednuti_za_osmi_lety_poskytovani_mobilni_specializovane_paliativni_pece.php weekly 0.7 /artkey/xon-202503-0001_casna_integrace_paliativni_pece_nejen_v_onkologii.php weekly 0.7 /artkey/xon-202503-0002_uzkost_deprese_a_delirium_v_nemocnicni_paliativni_peci_-_strucny_prehled.php weekly 0.7 /artkey/xon-202503-0003_vyznamna_role_existencialniho_distresu_pri_managementu_lecby_symptomu.php weekly 0.7 /artkey/xon-202503-0013_zaznelo_na_kongrese.php weekly 0.7 /artkey/xon-202503-0008_hypersenzitivni_lekove_reakce_a_desenzitizace_v_onkologii.php weekly 0.7 /magno/xon/2025/mn4.php weekly 0.7 /artkey/xon-202504-0014_radioterapie_dnes_mezi_klinickou_praxi_a_vedeckym_pokrokem.php weekly 0.7 /artkey/xon-202504-0006_trifluridin-tipiracil_bevacizumab_v_lecbe_metastatickeho_kolorektalniho_karcinomu_-_od_studie_sunlight_k_bezn.php weekly 0.7 /artkey/xon-202504-0007_durvalumab_v_lecbe_limitovaneho_stadia_sclc.php weekly 0.7 /artkey/xon-202504-0008_jak2_inhibitory_v_terapii_pacientu_s_myelofibrozou_a_anemii.php weekly 0.7 /artkey/xon-202504-0009_brachyterapie_karcinomu_prostaty_v_roce_2025_soucasny_stav_vyzvy_a_budouci_smery.php weekly 0.7 /artkey/xon-202504-0010_nadory_zlucovych_cest.php weekly 0.7 /artkey/xon-202504-0011_stereotakticka_radioterapie_cyberknife_ucinna_a_bezpecna_modalita_v_lecbe_relabujiciho_skvamozniho_karcinomu_h.php weekly 0.7 /artkey/xon-202504-0012_lecba_trifluridin_tipiracilem_a_bevacizumabem_po_rychle_progresi_karcinomu_konecniku_po_totalni_neoadjuvantni_t.php weekly 0.7 /artkey/xon-202504-0013_toxicita_kombinovane_imunoterapie_ipilimumabu_a_nivolumabu_u_pokrocileho_renalniho_karcinomu.php weekly 0.7 /artkey/xon-202504-0001_vliv_vybranych_faktoru_na_rozvoj_toxicity_radioterapie_u_pacientu_s_karcinomem_laryngu.php weekly 0.7 /artkey/xon-202504-0002_vliv_vybranych_vyzivovych_parametru_u_pacientu_s_nadory_jicnu_a_gastroezofagealni_junkce.php weekly 0.7 /artkey/xon-202504-0003_radioterapie_u_sarkomu_mekkych_tkani_hlavy_a_krku.php weekly 0.7 /artkey/xon-202504-0004_reiradiace_nadoru_orl_oblasti_ma_smysl_-_zkusenosti_a_vysledky_lecby_z_uro_1_lf_uk_a_fnb_od_r_2003_do_r_20.php weekly 0.7 /artkey/xon-202504-0005_uskali_larynx_zachovnych_protokolu_lecby_karcinomu_laryngu_a_hypofaryngu.php weekly 0.7 /artkey/xon-202504-0015_hypomagnezemie_jako_nejcastejsi_nediagnostikovana_iontova_nerovnovaha_v_klinicke_praxi_a_jak_ji_resit.php weekly 0.7 /magno/xon/2025/mn5.php weekly 0.7 /artkey/xon-202505-0012_nekolik_poznamek_k_lecbe_lokalne_pokrocileho_plicniho_karcinomu.php weekly 0.7 /artkey/xon-202505-0005_nove_trendy_v_lokalni_i_systemove_lecbe_uvealniho_melanomu.php weekly 0.7 /artkey/xon-202505-0006_soucasny_stav_precizni_mediciny_v_onkologii.php weekly 0.7 /artkey/xon-202505-0007_role_t-lymfocytarnich_subpopulaci_v_patogenezi_a_lecbe_b-nehodgkinskych_lymfomu.php weekly 0.7 /artkey/xon-202505-0008_pemigatinib_v_lecbe_metastatickeho_intrahepatalniho_cholangiocelularniho_karcinomu_s_alteraci_fgfr2.php weekly 0.7 /artkey/xon-202505-0009_skryta_hrozba_sarkomatoidni_transformace_germinalniho_nadoru.php weekly 0.7 /artkey/xon-202505-0010_dezmoplasticky_melanom_koze_vyrastajuci_na_zahlavi.php weekly 0.7 /artkey/xon-202505-0011_casna_diagnostika_imunitne_podminene_myozitidy_u_pacienta_leceneho_pembrolizumabem.php weekly 0.7 /artkey/xon-202505-0001_terapie_malobunecneho_plicniho_karcinomu.php weekly 0.7 /artkey/xon-202505-0002_lecba_inoperabilniho_nemalobunecneho_karcinomu_plic_stadia_iii.php weekly 0.7 /artkey/xon-202505-0003_imunoterapie_v_lecbe_metastatickeho_nemalobunecneho_karcinomu_plic.php weekly 0.7 /artkey/xon-202505-0004_aktualni_moznosti_cilene_lecby_nemalobunecneho_karcinomu_plic_v_ceske_republice.php weekly 0.7 /artkey/xon-202505-0013_zaznelo_na_49_rocniku_brnenskych_onkologickych_dnu_a_39_rocniku_konference_pro_nelekarske_zdravotnicke_prac.php weekly 0.7 /artkey/xon-202505-0014_zaznelo_na_49_rocniku_brnenskych_onkologickych_dnu_a_39_rocniku_konference_pro_nelekarske_zdravotnicke_prac.php weekly 0.7 /magno/xon/2024/mn1.php weekly 0.7 /flashbook/xon/2024/1.php monthly 0.2 /artkey/xon-202401-0017_novinky_v_onkogynekologii.php weekly 0.7 /artkey/xon-202401-0010_cholangiocelularni_karcinom_-_moznosti_lecby.php weekly 0.7 /artkey/xon-202401-0011_definitivni_protonova_chemoradioterapie_u_nadoru_krcniho_jicnu_-_predbezna_analyza_vysledku.php weekly 0.7 /artkey/xon-202401-0012_dostarlimab_v_1_linii_lecby_metastatickeho_a_rekurentniho_karcinomu_endometria.php weekly 0.7 /artkey/xon-202401-0013_androgen_deprivacni_lecba_a_antagonista_relugolix_v_praxi.php weekly 0.7 /artkey/xon-202401-0014_dlouhodobe_kvalitni_preziti_mladeho_muze_s_metastatickym_karcinomem_pankreatu_predleceneho_rezimem_gemcitabin.php weekly 0.7 /artkey/xon-202401-0015_svetlobunkovy_variant_atypickeho_fibroxantomu_u_pacienta_s_viacpocetnymi_keratinocytovymi_karcinomami_koze.php weekly 0.7 /artkey/xon-202401-0016_rekonstrukcia_limbergovym_lalokom_po_excizii_bazocelularneho_karcinomu.php weekly 0.7 /artkey/xon-202401-0001_chirurgicka_lecba_zhoubnych_novotvaru_hrdla_delozniho.php weekly 0.7 /artkey/xon-202401-0002_chirurgicka_lecba_zhoubnych_nadoru_vajecniku.php weekly 0.7 /artkey/xon-202401-0003_nechirurgicka_lecba_karcinomu_hrdla_delohy.php weekly 0.7 /artkey/xon-202401-0004_novinky_v_systemove_lecbe_karcinomu_endometria.php weekly 0.7 /artkey/xon-202401-0005_lecba_metastatickeho_karcinomu_endometria.php weekly 0.7 /artkey/xon-202401-0006_systemova_lecba_karcinomu_ovaria.php weekly 0.7 /artkey/xon-202401-0007_her-2_low_karcinom_prsu.php weekly 0.7 /artkey/xon-202401-0008_zmeny_v_pristupu_k_lokoregionalni_terapii_casneho_karcinomu_prsu.php weekly 0.7 /artkey/xon-202401-0009_chirurgicka_lecba_karcinomu_endometria.php weekly 0.7 /magno/xon/2024/mn2.php weekly 0.7 /flashbook/xon/2024/2.php monthly 0.2 /artkey/xon-202402-0014_moderni_terapeuticke_pristupy_v_hematoonkologii.php weekly 0.7 /artkey/xon-202402-0006_ruxolitinib_v_lecbe_polycythemia_vera_-_co_vsechno_jeste_nevime.php weekly 0.7 /artkey/xon-202402-0007_pece_o_kuzi_onkologickych_pacientu.php weekly 0.7 /artkey/xon-202402-0008_hepatocelularni_karcinom_-_systemova_lecba_v_roce_2024.php weekly 0.7 /artkey/xon-202402-0009_nezadouci_ucinky_radioterapie_a_radiobiologicke_modelovani.php weekly 0.7 /artkey/xon-202402-0010_hypofosfatemie_-_prehlizeny_elektrolythypofosfatemie_u_pacientky_s_karcinomem_zlucovych_cest.php weekly 0.7 /artkey/xon-202402-0011_atypicky_intradermalny_hladkosvalovy_tumor_kozny_leiomyosarkom_opis_pripadu.php weekly 0.7 /artkey/xon-202402-0001_soucasne_moznosti_cilene_terapie_u_chronicke_lymfocytarni_leukemie.php weekly 0.7 /artkey/xon-202402-0002_rituximab-venetoklax_ve_druhe_linii_lecby_chronicke_lymfocytarni_leukemie_u_pacienta_s_mutaci_tp53.php weekly 0.7 /artkey/xon-202402-0003_aktualni_postaveni_car_t-lymfocytu_v_terapii_non-hodgkinskych_lymfomu.php weekly 0.7 /artkey/xon-202402-0004_novinky_v_terapii_difuzniho_velkobunecneho_b-lymfomu.php weekly 0.7 /artkey/xon-202402-0005_vyznam_mikrobiomu_u_hematoonkologickych_pacientu.php weekly 0.7 /artkey/xon-202402-0012_strategie_zvladani_u_onkologicky_nemocnych_senioru_-_implikace_pro_osetrovatelskou_peci.php weekly 0.7 /artkey/xon-202402-0013_strucna_historie_lecby_karcinomu_ovaria.php weekly 0.7 /magno/xon/2024/mn3.php weekly 0.7 /flashbook/xon/2024/3.php monthly 0.2 /artkey/xon-202403-0015_nevrati_se_nikdy_k_nam_8230.php weekly 0.7 /artkey/xon-202403-0006_asciminib_v_lecbe_chronicke_myeloidni_leukemie.php weekly 0.7 /artkey/xon-202403-0007_soucasne_terapeuticke_strategie_lecby_ocniho_melanomu.php weekly 0.7 /artkey/xon-202403-0008_brigatinib_v_lecbe_pacientu_s_alk_pozitivnim_nsclc_-_vysledky_studii_brightstar_a_alta-1l.php weekly 0.7 /artkey/xon-202403-0009_mrna_vakciny_v_lecbe_melanomu.php weekly 0.7 /artkey/xon-202403-0010_aktualni_moznosti_lecby_her2_metastatickeho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-202403-0011_kombinovana_terapie_u_pokrocileho_primarne_metastatickeho_hormonalne_senzitivniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-202403-0012_individualizovana_terapie_u_pacienta_s_karcinomem_prostaty.php weekly 0.7 /artkey/xon-202403-0013_pembrolizumab_v_lecbe_nemalobunecneho_karcinomu_plic_s_metastazami_do_ledvin.php weekly 0.7 /artkey/xon-202403-0001_pristup_k_lecbe_visceralnich_metastaz_u_metastatickeho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-202403-0002_apalutamid_v_prvni_linii_komplexni_onkologicke_lecby_pacienta_s_metastatickym_hormonalne_senzitivnim_karcinomem.php weekly 0.7 /artkey/xon-202403-0003_olaparib_v_lecbe_metastatickeho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-202403-0004_stereotakticka_radioterapie_v_lecbe_karcinomu_prostaty.php weekly 0.7 /artkey/xon-202403-0005_adjuvantni_lecba_renalniho_karcinomu_-_nove_vysledky_studie_keynote-564.php weekly 0.7 /artkey/xon-202403-0014_samovysetrenie_prsnikov_ako_d_lezita_sucast_prevencie_rakoviny_prsnika_u_zien.php weekly 0.7 /magno/xon/2024/mn4.php weekly 0.7 /flashbook/xon/2024/4.php monthly 0.2 /artkey/xon-202404-0011_lecba_nadoru_zaludku.php weekly 0.7 /artkey/xon-202404-0006_vyuziti_kontrastnich_latek_pri_planovacim_ct_v_radioterapii.php weekly 0.7 /artkey/xon-202404-0007_efekt_lecby_kombinaci_trifluridin_tipiracilu_s_bevacizumabem.php weekly 0.7 /artkey/xon-202404-0008_fanconiho_syndrom_po_podani_ifosfamidu_u_pacientky_s_ewingovym_sarkomem.php weekly 0.7 /artkey/xon-202404-0009_cemiplimab_v_lecbe_lokoregionalne_metastazujiciho_kozniho_spinocelularniho_karcinomu.php weekly 0.7 /artkey/xon-202404-0010_fruchintinib_v_lecbe_metastatickeho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-202404-0001_lokoregionalne_pokrocily_karcinom_gastroesophagealni_junkce_a_zaludku_minulost_soucasnost_budoucnost.php weekly 0.7 /artkey/xon-202404-0002_her2_negativni_metastaticky_karcinom_zaludku.php weekly 0.7 /artkey/xon-202404-0003_her2_pozitivni_metastaticky_karcinom_zaludku.php weekly 0.7 /artkey/xon-202404-0004_nove_cile_v_lecbe_karcinomu_zaludku.php weekly 0.7 /artkey/xon-202404-0005_trifluridin_tipiracil_ve_4_linii_lecby_metastatickeho_karcinomu_distalniho_jicnu_a_kardie.php weekly 0.7 /magno/xon/2024/mn5.php weekly 0.7 /flashbook/xon/2024/5.php monthly 0.2 /artkey/xon-202405-0012_nove_moznosti_v_diagnostice_a_terapii_karcinomu_ovaria.php weekly 0.7 /artkey/xon-202405-0007_inovace_a_vyvoj_v_terapii_chronicke_lymfocytarni_leukemie.php weekly 0.7 /artkey/xon-202405-0008_picc-port_-_novy_druh_dlouhodobeho_zilniho_vstupu_pro_onkologicke_pacienty.php weekly 0.7 /artkey/xon-202405-0009_casna_ocni_toxicita_cilene_lecby_metastazujiciho_melanomu.php weekly 0.7 /artkey/xon-202405-0010_emicizumab_v_lecbe_ziskane_hemofilie_a_-_nase_prvni_zkusenost.php weekly 0.7 /artkey/xon-202405-0011_lecba_sekundarni_imunodeficience_u_hematoonkologickych_pacientu.php weekly 0.7 /artkey/xon-202405-0013_cesta_k_digitalni_medicine_rozhovor_s_mudr_katarinou_petrakovou_ph_d_8211_pohled_onkologa_na_vyhody_i_li.php weekly 0.7 /artkey/xon-202405-0001_hypertermicka_intraperitonealni_chemoterapie_v_lecbe_pokrocileho_ovarialniho_karcinomu_-_novy_trend_anebo_slep.php weekly 0.7 /artkey/xon-202405-0002_serozni_tubarni_intraepitelialni_karcinom_a_postup_pri_jeho_nahodnem_nalezu.php weekly 0.7 /artkey/xon-202405-0003_nahodny_nalez_adenokarcinomu_delozniho_cipku_po_komplikaci_cisarskeho_rezu.php weekly 0.7 /artkey/xon-202405-0004_parp_inhibitory_v_terapii_pokrocileho_metastatickeho_nebo_recidivujiciho_karcinomu_endometria.php weekly 0.7 /artkey/xon-202405-0005_hipec_-_kazuistika_ovarialniho_karcinomu.php weekly 0.7 /artkey/xon-202405-0006_imunoterapie_v_lecbe_pokrocilych_a_recidivujicich_stadii_karcinomu_delozniho_hrdla.php weekly 0.7 /magno/xon/2024/mn88.php weekly 0.7 /artkey/xon-202488-0001_jak_efektivne_vyuzit_venetoklax_v_lecbe_cll.php weekly 0.7 /magno/xon/2024/mn89.php weekly 0.7 /artkey/xon-202489-0001_management_diagnostiky_a_lecby_akutni_myeloidni_leukemie.php weekly 0.7 /magno/xon/2024/mn90.php weekly 0.7 /artkey/xon-202490-0006_enfortumab_vedotin_aneb_zacatek_cesty_k_vyleceni_pokrocileho_urotelialniho_karcinomu.php weekly 0.7 /artkey/xon-202490-0001_enfortumab_vedotin_v_terapii_generalizovaneho_urotelialniho_karcinomu_ledvinne_panvicky_a_mocovodu.php weekly 0.7 /artkey/xon-202490-0002_rane_zkusenosti_s_enfortumab_vedotinem_u_pacientu_s_metastatickym_tumorem_mocoveho_mechyre.php weekly 0.7 /artkey/xon-202490-0003_padcev_enfortumab_vedotin_-_nova_moznost_lecby_urotelialniho_karcinomu.php weekly 0.7 /artkey/xon-202490-0004_enfortumab_vedotin_v_lecbe_urotelialniho_karcinomu_mocoveho_mechyre.php weekly 0.7 /artkey/xon-202490-0005_efekt_lecby_enfortumab_vedotinu_u_pacienta_s_generalizovanym_urotelialnim_karcinomem_predlecenym_platinou_a_ave.php weekly 0.7 /magno/xon/2023/mn1.php weekly 0.7 /flashbook/xon/2023/1.php monthly 0.2 /artkey/xon-202301-0016_karcinom_plic_v_roce_2023_8211_mene_zname_aspekty_nemoci.php weekly 0.7 /artkey/xon-202301-0005_postaveni_imunoterapie_v_adjuvantni_lecbe_invazivniho_urotelialniho_karcinomu.php weekly 0.7 /artkey/xon-202301-0006_vyuziti_pet_mr_u_karcinomu_rekta.php weekly 0.7 /artkey/xon-202301-0007_jsme_v_ere_totalni_neoadjuvantni_terapie_u_karcinomu_rekta.php weekly 0.7 /artkey/xon-202301-0008_problematika_posuzovani_zdravotniho_stavu_pro_ucely_prispevku_na_zvlastni_pomucku_a_prukazu_osoby_zdravotne_pos.php weekly 0.7 /artkey/xon-202301-0009_nevoidny_melanom_ako_diagnosticky_problem.php weekly 0.7 /artkey/xon-202301-0010_mechanismy_rezistence_na_imunoterapii_melanomu.php weekly 0.7 /artkey/xon-202301-0011_kazuistiky_pacientu_s_alk_pozitivnim_nsclc_a_mozkovymi_metastazami.php weekly 0.7 /artkey/xon-202301-0012_cemiplimab_v_lecbe_lokalne_pokrocileho_nsclc.php weekly 0.7 /artkey/xon-202301-0013_studie_checkmate_9la_komentar_a_kazuistika_pacienta_s_mozeckovou_metastazou_a_negativni_pd-l1_expresi.php weekly 0.7 /artkey/xon-202301-0014_svetlobunecny_renalni_karcinom_se_sarkomatoidni_dediferenciaci_v_lecbe_imunoterapii.php weekly 0.7 /artkey/xon-202301-0015_rizika_spojena_s_peci_o_centralni_zilni_katetry_u_detskeho_pacienta_v_paliativni_peci.php weekly 0.7 /artkey/xon-202301-0001_aktualni_role_imunoterapie_v_lecbe_karcinomu_plic.php weekly 0.7 /artkey/xon-202301-0002_perspektivy_v_lecbe_mene_castych_mutaci_u_pacientu_s_nemalobunecnymi_karcinomy_plic.php weekly 0.7 /artkey/xon-202301-0003_nove_diagnosticke_a_lecebne_postupy_u_maligniho_pleuralniho_vypotku.php weekly 0.7 /artkey/xon-202301-0004_zkusenosti_s_lecbou_karcinomu_plic_z_realne_klinicke_praxe_-_poznatky_z_registru_tulung_a_lucas.php weekly 0.7 /magno/xon/2023/mn2.php weekly 0.7 /flashbook/xon/2023/2.php monthly 0.2 /artkey/xon-202302-0011_karcinom_pankreatu_8211_zmena_k_lepsimu.php weekly 0.7 /artkey/xon-202302-0006_vliv_cilene_lecby_braf_a_mek_inhibitory_na_imunitni_system_u_metastazujiciho_melanomu.php weekly 0.7 /artkey/xon-202302-0007_rekonstrukce_prsu_a_radioterapie.php weekly 0.7 /artkey/xon-202302-0008_typy_a_charakter_renalnich_lezi_-_diagnostika_lecba_a_prognoza.php weekly 0.7 /artkey/xon-202302-0009_dlouhodobe_prezivani_pacientky_s_diseminovanym_adenokarcinomem_vaterske_papily_komplexni_terapeuticky_pristup.php weekly 0.7 /artkey/xon-202302-0010_hidradenokarcinom_vyrastajuci_v_podpazusi_-_opis_zriedkaveho_pripadu.php weekly 0.7 /artkey/xon-202302-0001_chirurgicka_lecba_resekabilniho_a_hranicne_resekabilniho_karcinomu_slinivky_brisni.php weekly 0.7 /artkey/xon-202302-0002_je_v_soucasne_dobe_indikovana_chirurgicka_lecba_jaternich_metastaz_adenokarcinomu_pankreatu.php weekly 0.7 /artkey/xon-202302-0003_role_radioterapie_v_lecbe_nadoru_pankreatu.php weekly 0.7 /artkey/xon-202302-0004_personalizovana_terapie_karcinomu_pankreatu.php weekly 0.7 /artkey/xon-202302-0005_metastaticky_karcinom_pankreatu_a_personalizovana_terapie_-_kazuistika.php weekly 0.7 /magno/xon/2023/mn3.php weekly 0.7 /flashbook/xon/2023/3.php monthly 0.2 /artkey/xon-202303-0016_vsechno_co_jste_kdy_chteli_vedet_o_karcinomu_prsu_u_mladych_zen_ale_bali_jste_se_zeptat.php weekly 0.7 /artkey/xon-202303-0008_malobunecny_karcinom_plic_soucasna_lecba_a_perspektivy.php weekly 0.7 /artkey/xon-202303-0009_snasenlivost_antidepresiv_a_mechanismy_jejich_nezadoucich_ucinku_s_ohledem_na_jejich_pouziti_u_onkologicky_nemo.php weekly 0.7 /artkey/xon-202303-0010_rechallenge_anti-egfr_preparaty.php weekly 0.7 /artkey/xon-202303-0011_inhibitory_brutonovy_tyrosinkinazy_a_jejich_soucasne_postaveni_v_lecbe_chronicke_lymfocytarni_leukemie.php weekly 0.7 /artkey/xon-202303-0012_miniinvazivni_lecba_a_aktivni_sledovani_renalniho_karcinomu.php weekly 0.7 /artkey/xon-202303-0013_lecba_trifluridin_tipiracilem_ve_iii_linii_lecby_metastatickeho_kolorektalniho_karcinomu_u_pacientky_s_projevy.php weekly 0.7 /artkey/xon-202303-0014_pacientka_s_upgradujicim_gangliogliomem.php weekly 0.7 /artkey/xon-202303-0001_adjuvantni_hormonalni_terapie_mladych_zen_s_casnym_karcinomem_prsu_v_roce_2023.php weekly 0.7 /artkey/xon-202303-0002_systemova_lecba_karcinomu_prsu_u_mladych_pacientek_se_zarodecnou_mutaci_v_genech_brca1_a_brca2.php weekly 0.7 /artkey/xon-202303-0003_specifika_lecby_her2_pozitivniho_karcinomu_prsu_u_mladych_pacientek.php weekly 0.7 /artkey/xon-202303-0004_strategie_lecby_triple-negativniho_karcinomu_prsu_u_mladych_pacientek_s_karcinomem_prsu_-_lecime_je_jinak.php weekly 0.7 /artkey/xon-202303-0005_sacituzumab_govitekan_v_lecbe_metastatickeho_triple_negativniho_karcinomu_prsu.php weekly 0.7 /artkey/xon-202303-0006_zachovani_fertility_u_mladych_pacientek_s_karcinomem_prsu_vcetne_nosicek_mutaci_v_genech_brca1_brca2.php weekly 0.7 /artkey/xon-202303-0007_karcinom_prsu_a_gravidita.php weekly 0.7 /artkey/xon-202303-0015_lecba_pacientu_s_mnohocetnym_myelomem_po_expozici_lenalidomidu_a_postaveni_pripravku_ninlaro_v_terapeuticke_sek.php weekly 0.7 /magno/xon/2023/mn4.php weekly 0.7 /flashbook/xon/2023/4.php monthly 0.2 /artkey/xon-202304-0014_nove_trendy_v_lecbe_pokrocileho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-202304-0005_neo-_adjuvantni_imunoterapie_a_cilena_lecba_nemalobunecneho_plicniho_karcinomu.php weekly 0.7 /artkey/xon-202304-0006_postaveni_ruxolitinibu_v_lecbe_prave_polycytemie.php weekly 0.7 /artkey/xon-202304-0007_soucasne_postaveni_nefrektomie_v_lecbe_metastatickeho_renalniho_karcinomu.php weekly 0.7 /artkey/xon-202304-0008_cemiplimab_monoterapie_a_kombinacni_lecba_nsclc_-_analyza_lokalne_pokrocilych_stadii.php weekly 0.7 /artkey/xon-202304-0009_konsolidacni_lecba_brentuximab_vedotinem_u_pacientu_s_relabujicim_refrakternim_klasickym_hodgkinovym_lymfomem_p.php weekly 0.7 /artkey/xon-202304-0010_moderni_pristup_k_lecbe_chronicke_lymfocytarni_leukemie.php weekly 0.7 /artkey/xon-202304-0011_vyuziti_imunoterapie_a_cilene_lecby_u_richterovy_transformace.php weekly 0.7 /artkey/xon-202304-0012_nivolumab_v_lecbe_predlecenych_pacientu_s_metastatickym_kolorektalnim_karcinomem_s_vysokou_mikrosatelitovou_nes.php weekly 0.7 /artkey/xon-202304-0013_efekt_imunoterapie_a_radioterapie_v_lecbe_karcinomu_z_merkelovych_bunek_u_pacienta_s_myelodysplastickym_syndrom.php weekly 0.7 /artkey/xon-202304-0001_imunoterapie_metastatickeho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-202304-0002_lecba_metastatickeho_kolorektalniho_karcinomu_s_mutaci_braf_v600e.php weekly 0.7 /artkey/xon-202304-0003_moznosti_a_opodstatnenost_znovunasazeni_anti-egfr_lecby_u_predlecenych_ras_wild_pokrocilych_kolorektalnich_karc.php weekly 0.7 /artkey/xon-202304-0004_lecba_metastatickeho_kolorektalniho_karcinomu_-_3_a_vyssi_linie.php weekly 0.7 /magno/xon/2023/mn5.php weekly 0.7 /flashbook/xon/2023/5.php monthly 0.2 /artkey/xon-202305-0016_geneticke_nadorove_predispozicni_syndromy.php weekly 0.7 /artkey/xon-202305-0006_casove_omezena_terapie_u_pacientu_s_chronickou_lymfocytarni_leukemii.php weekly 0.7 /artkey/xon-202305-0007_soucasne_moznosti_lecby_braf_v600e_mutovaneho_metastatickeho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-202305-0008_trendy_v_lecbe_metastatickeho_kastracne_senzitivniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-202305-0009_lonsurf_bevacizumab_novy_standard_lecby_3_linie_metastatickeho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-202305-0010_opioidni_lecba_onkologicky_nemocnych_v_roce_2023.php weekly 0.7 /artkey/xon-202305-0011_adjuvantni_lecba_kolorektalniho_karcinomu_stadia_ii_a_iii.php weekly 0.7 /artkey/xon-202305-0012_kardiovaskularni_nezadouci_ucinky_inhibitoru_signalnich_drah_v_terapii_chronicke_lymfocytarni_leukemie.php weekly 0.7 /artkey/xon-202305-0013_hidradenitis_suppurativa_-_diagnosticka_dilema_v_ambulancii_onkologa.php weekly 0.7 /artkey/xon-202305-0014_metastaticky_extragonadalni_choriokarcinom_s_zivot_ohrozujicimi_komplikacemi_u_mladeho_pacienta_intenzivni_lec.php weekly 0.7 /artkey/xon-202305-0015_management_nezadoucich_ucinku_v_prubehu_lecby_karcinomu_anu.php weekly 0.7 /artkey/xon-202305-0001_extremne_vzacny_spinalni_nador_na_podklade_li-fraumeni_syndromu.php weekly 0.7 /artkey/xon-202305-0002_tranzientni_abnormalni_myelopoeza_a_akutni_leukemie_u_deti_s_downovym_syndromem.php weekly 0.7 /artkey/xon-202305-0003_rizika_hematoonkologickych_onemocneni_u_syndromu_noonanove.php weekly 0.7 /artkey/xon-202305-0004_tinnitus_-_uvodni_priznak_synchronniho_vyskytu_paragangliomu_a_renalniho_karcinomu_u_germinalni_mutace_sdhb_gen.php weekly 0.7 /artkey/xon-202305-0005_hepatoblastom_u_trech_sourozencu_na_podklade_familiarni_adenomatozni_polypozy.php weekly 0.7 /magno/xon/2023/mn88.php weekly 0.7 /artkey/xon-202388-0001_imunoterapie_vstoupila_do_1_linie_lecby_zhoubnych_nadoru_jicnu_gastroezofagealni_junkce_a_zaludku.php weekly 0.7 /magno/xon/2023/mn89.php weekly 0.7 /artkey/xon-202389-0001_syndrom_obstrukce_sinusoid_venookluzivni_nemoc_jater.php weekly 0.7 /magno/xon/2022/mn1.php weekly 0.7 /artkey/xon-202201-0011_renalni_karcinom_v_roce_2021.php weekly 0.7 /artkey/xon-202201-0005_liecba_akutnej_myeloidnej_leukemie_starsich_pacientov_nad_60_rokov_v_ere_cielenej_terapie_up-to-date.php weekly 0.7 /artkey/xon-202201-0006_moznosti_lecby_karcinomu_rekta.php weekly 0.7 /artkey/xon-202201-0007_aktuality_moznosti_a_rozpory_nemocenskeho_pojisteni.php weekly 0.7 /artkey/xon-202201-0008_chirurgicka_lecba_loziska_ve_frontalni_kosti_u_pacienta_s_mnohocetnym_myelomem.php weekly 0.7 /artkey/xon-202201-0010_tiskova_zprava_13_pragueonco.php weekly 0.7 /artkey/xon-202201-0001_zobrazovaci_metody_a_jejich_role_ve_sledovani_po_operaci_pro_karcinom_ledviny.php weekly 0.7 /artkey/xon-202201-0002_nezadouci_ucinky_kombinovane_imunoterapie_u_nadoru_ledvin_plic_a_melanomu.php weekly 0.7 /artkey/xon-202201-0003_vyznam_radioterapie_u_renalniho_karcinomu_a_moznosti_jeji_kombinace_s_imunoterapii.php weekly 0.7 /artkey/xon-202201-0004_nove_moznosti_lecby_metastatickeho_renalniho_karcinomu.php weekly 0.7 /artkey/xon-202201-0009_prakticke_strategie_sdelovani_zavaznych_zprav_v_onkologii.php weekly 0.7 /magno/xon/2022/mn2.php weekly 0.7 /artkey/xon-202202-0001_problematika_paliativni_mediciny_v_kontextu_detske_onkologie.php weekly 0.7 /artkey/xon-202202-0007_ockovani_onkologickych_pacientu.php weekly 0.7 /artkey/xon-202202-0008_lokalni_terapie_uvealnich_melanomu.php weekly 0.7 /artkey/xon-202202-0009_moznosti_intervence_a_lecby_vybranych_gastrointestinalnich_obtizi_provazejicich_onkologicka_onemocneni.php weekly 0.7 /artkey/xon-202202-0010_problematika_posuzovani_invalidity_u_osob_s_onkologickym_onemocnenim.php weekly 0.7 /artkey/xon-202202-0011_nivolumab_ve_druhe_linii_lecby_pacientu_s_pokrocilym_nemalobunecnym_plicnim_karcinomem.php weekly 0.7 /artkey/xon-202202-0002_role_psychologa_paliativniho_tymu_v_peci_o_deti_s_hr_neuroblastomem.php weekly 0.7 /artkey/xon-202202-0003_herni_specialista_a_jeho_uloha_v_peci_o_onkologicky_nemocne_deti_a_dospivajicizahranicni_zkusenosti_psychologa.php weekly 0.7 /artkey/xon-202202-0004_soubezna_role_sestry_na_detske_onkologii_a_v_paliativnim_tymuprofesni_a_kompetencni_vyzvy_pri_praci_s_onkologic.php weekly 0.7 /artkey/xon-202202-0005_socialni_prace_u_onkologicky_nemocnych_deti_v_peci_detskeho_paliativniho_tymu_fn_motolkazuistika_16leteho_pacie.php weekly 0.7 /artkey/xon-202202-0006_role_lekare_v_komunikaci_s_pacientem_a_jeho_rodinou_v_kontextu_detske_onkologiejak_se_zapojuje_lekar_paliativni.php weekly 0.7 /magno/xon/2022/mn3.php weekly 0.7 /artkey/xon-202203-0011_imunoterapie_v_mene_castych_indikacich.php weekly 0.7 /artkey/xon-202203-0008_problematika_posuzovani_stupne_zavislosti_pro_ucely_prispevku_na_peci_u_osob_s_onkologickym_onemocnenim.php weekly 0.7 /artkey/xon-202203-0009_zavazna_sekundarni_imunitni_trombocytopenie_u_nemocne_s_chronickou_lymfocytarni_leukemii.php weekly 0.7 /artkey/xon-202203-0010_chemorezistentni_myelosarkom_reagujici_na_zachrannou_terapii_kombinaci_azacitidin_a_venetoclax.php weekly 0.7 /artkey/xon-202203-0002_potencialni_checkpoint_inhibitory_vyuzitelne_v_lecbe_nadoru.php weekly 0.7 /artkey/xon-202203-0003_novinky_imunoterapie_v_lecbe_dmmr_msi-h_crc.php weekly 0.7 /artkey/xon-202203-0004_imunoterapie_nadoru_horniho_gastrointestinalniho_traktu.php weekly 0.7 /artkey/xon-202203-0005_moznosti_imunoterapie_adenokarcinomu_slinivky_brisni.php weekly 0.7 /artkey/xon-202203-0006_imunoterapie_v_lecbe_metastatickeho_uvealniho_melanomu.php weekly 0.7 /artkey/xon-202203-0007_imunoterapie_nemelanomovych_nadoru_kuze.php weekly 0.7 /magno/xon/2022/mn4.php weekly 0.7 /artkey/xon-202204-0013_radioterapie_v_mene_castych_indikacich.php weekly 0.7 /artkey/xon-202204-0006_geneticke_testovani_u_karcinomu_ovaria.php weekly 0.7 /artkey/xon-202204-0007_novinky_v_lecbe_nadoru_gastrointestinalniho_traktu.php weekly 0.7 /artkey/xon-202204-0008_nove_moznosti_liecby_koznych_t-bunkovych_lymfomov.php weekly 0.7 /artkey/xon-202204-0009_lecba_seniora_s_kardiovaskularnimi_komorbiditami_pomoci_inhibitoru_kontrolnich_bodu.php weekly 0.7 /artkey/xon-202204-0010_terapie_trifluridinem_tipiracilem_u_pacienta_s_mucinoznim_metastatickym_kolorektalnim_karcinomem.php weekly 0.7 /artkey/xon-202204-0011_rychla_hluboka_a_dlouhotrvajici_odpoved_na_cetuximab.php weekly 0.7 /artkey/xon-202204-0001_vliv_komorbidit_a_faktoru_zivotniho_stylu_na_vysledky_lecby_u_pacientu_s_karcinomem_laryngu_-_retrospektivni_ho.php weekly 0.7 /artkey/xon-202204-0002_interni_klinicky_audit_na_radioterapeutickem_pracovisti_-_vlastni_zkusenost.php weekly 0.7 /artkey/xon-202204-0003_patologicke_fraktury_jako_pozdni_komplikace_pooperacni_radioterapie_sarkomu_mekkych_tkani_v_oblasti_dolnich_kon.php weekly 0.7 /artkey/xon-202204-0004_podpurna_pece_u_pacientu_podstupujicich_radioterapii_pro_nadory_hlavy_a_krku.php weekly 0.7 /artkey/xon-202204-0005_specifika_onkologicke_pece_u_lgbtqi_pacientu.php weekly 0.7 /artkey/xon-202204-0012_role_sestry_v_podpore_posttraumatickeho_rustu_u_onkologicky_nemocnych_a_jejich_blizkych.php weekly 0.7 /magno/xon/2022/mn5.php weekly 0.7 /artkey/xon-202205-0010_deset_let_cinnosti_prazskeho_protonoveho_centra.php weekly 0.7 /artkey/xon-202205-0006_kombinace_axitinib_s_avelumabem_v_lecbe_metastatickeho_karcinomu_ledviny.php weekly 0.7 /artkey/xon-202205-0007_lokalne_pokrocily_karcinom_pankreatu_-_kompletni_morfo-metabolicka_odpoved_primarniho_nadoru_leceneho_nechirurg.php weekly 0.7 /artkey/xon-202205-0001_co_prinasi_protonova_radioterapie_nadoru_jicnu.php weekly 0.7 /artkey/xon-202205-0002_davkova_eskalace_v_lecbe_nsclc_protonovou_radioterapii.php weekly 0.7 /artkey/xon-202205-0003_hypofrakcinovana_protonova_radioterapie_karcinomu_prostaty_-_6leta_data.php weekly 0.7 /artkey/xon-202205-0004_protonova_terapie_v_lecbe_meningiomu.php weekly 0.7 /artkey/xon-202205-0005_proveditelnost_dozimetricke_hodnoceni_a_casne_vysledky_protonove_radioterapie_v_lecbe_bilateralniho_karcinomu.php weekly 0.7 /artkey/xon-202205-0009_osetrovatelsky_management_unavy_u_pacientu_s_onkologickym_onemocnenim.php weekly 0.7 /artkey/xon-202205-0008_farmakologicky_profil_-_trastuzumab_emtansin.php weekly 0.7 /magno/xon/2022/mn6.php weekly 0.7 /artkey/xon-202206-0012_podpurna_a_paliativni_lecba_v_onkologii.php weekly 0.7 /artkey/xon-202206-0006_testikularni_nadory_a_radioterapie_-_minireview.php weekly 0.7 /artkey/xon-202206-0007_novinky_v_lecbe_analniho_spinocelularniho_karcinomu.php weekly 0.7 /artkey/xon-202206-0008_maligni_obstrukce_mocovodu.php weekly 0.7 /artkey/xon-202206-0009_populacni_pilotni_program_casneho_zachytu_karcinomu_plic_v_cr_vysledky_prvniho_datoveho_auditu.php weekly 0.7 /artkey/xon-202206-0010_schwannomatoza_paterniho_kanalu_-_kazuistika_otce_a_dcery.php weekly 0.7 /artkey/xon-202206-0001_nekolik_poznamek_k_organizaci_paliativni_pece_v_onkologickych_centrech_podle_narodniho_onkologickeho_planu_cr_2.php weekly 0.7 /artkey/xon-202206-0002_role_luzkoveho_hospice_v_paliativni_peci.php weekly 0.7 /artkey/xon-202206-0003_domaci_hospicova_pece_pro_onkologicke_pacienty.php weekly 0.7 /artkey/xon-202206-0004_moznosti_radioterapie_v_paliativni_peci.php weekly 0.7 /artkey/xon-202206-0005_paliativni_pece_o_nemocne_s_primarnim_nadorem_mozku.php weekly 0.7 /artkey/xon-202206-0011_zdravotnictvi_prvni_ceskoslovenske_republiky_a_jeji_pristup_k_onkologickym_nemocem.php weekly 0.7 /magno/xon/2022/mn88.php weekly 0.7 /flashbook/xon/2022/88.php monthly 0.2 /artkey/xon-202288-0001_monoklonalni_gamapatie_nejisteho_vyznamu_a_monoklonalni_gamapatie_klinickeho_vyznamu.php weekly 0.7 /artkey/xon-202288-0002_plazmocelularni_malignity_mnohocetny_myelom_solitarni_plazmocytom_a_plazmocelularni_leukemie_prehled_klinic.php weekly 0.7 /artkey/xon-202288-0003_monoklonalni_gamapatie_nejisteho_vyznamu_a_monoklonalni_gamapatie_klinickeho_vyznamu.php weekly 0.7 /artkey/xon-202288-0004_nekrobioticky_xantogranulom_a_monoklonalni_gamapatie.php weekly 0.7 /artkey/xon-202288-0005_prehled_prinosu_daratumumabu_pro_lecbu_vsech_monoklonalnich_gamapatii_ale_i_dalsich_nemoci_a_vlastni_zkusenost.php weekly 0.7 /artkey/xon-202288-0006_waldenstr_mova_makroglobulinemie_klinicke_priznaky_prehled_lecebnych_moznosti_a_vlastni_zkusenosti_s_lecbou_i.php weekly 0.7 /artkey/xon-202288-0007_socialni_a_psychicke_vlivy_na_prubeh_nemoci.php weekly 0.7 /artkey/xon-202288-0008_monoklonalni_gamapatie_-_uvodni_slovo_k_supplementu.php weekly 0.7 /magno/xon/2021/mn1.php weekly 0.7 /artkey/xon-202101-0009_nutricni_pece_v_8239_onkologii.php weekly 0.7 /artkey/xon-202101-0005_kozni_komplikace_u_onkologickych_pacientu.php weekly 0.7 /artkey/xon-202101-0006_vyznam_pohybovej_aktivity_a_rehabilitacie_u_pacientov_s_kolorektalnym_karcinomom.php weekly 0.7 /artkey/xon-202101-0007_lecba_nemetastatickeho_kastracne_rezistentniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-202101-0008_i_pacient_s_braf_mutovanym_malignim_melanomem_ma_sanci_na_dlouhodobe_preziti.php weekly 0.7 /artkey/xon-202101-0001_diagnostika_malnutrice_je_snadne_poznat_pacienta_ktery_potrebuje_podporu.php weekly 0.7 /artkey/xon-202101-0002_nutricni_a_protinadorova_terapie_u_onkologickych_pacientu_s_nizkou_svalovou_hmotou.php weekly 0.7 /artkey/xon-202101-0003_parenteralni_vyziva_v_onkologii.php weekly 0.7 /artkey/xon-202101-0004_ne_bezpecne_diety_u_onkologicky_nemocnych.php weekly 0.7 /magno/xon/2021/mn2.php weekly 0.7 /artkey/xon-202102-0011_o_nadorech_hlavy_a_krku_v_dobe_covidu.php weekly 0.7 /artkey/xon-202102-0006_virova_hepatitida_b_a_ockovani_ve_vztahu_k_nadorovym_onemocnenim.php weekly 0.7 /artkey/xon-202102-0007_lecba_relabujiciho_a_refrakterniho_mnohocetneho_myelomu.php weekly 0.7 /artkey/xon-202102-0009_lokalne_pokrocily_karcinom_delozniho_hrdla_-_zmena_puvodni_indikace_paliativni_radioterapie_na_radikalni_radiot.php weekly 0.7 /artkey/xon-202102-0010_konsenzualni_doporuceni_ceske_kooperativni_skupiny_pro_nadory_hlavy_a_krku_2019_definice_resekcnich_okraju.php weekly 0.7 /artkey/xon-202102-0001_metastaticky_nador_slinne_zlazy.php weekly 0.7 /artkey/xon-202102-0002_vyznam_stomatologickeho_osetreni_pred_radioterapii_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-202102-0003_soucasne_moznosti_reiradiace_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-202102-0004_totalni_laryngektomie_nebo_larynx-zachovny_postup_aktualni_lecebne_pristupy.php weekly 0.7 /artkey/xon-202102-0005_vyznam_imunitniho_infiltratu_v_nadorovem_mikroprostredi_karcinomu_hlavy_a_krku.php weekly 0.7 /artkey/xon-202102-0008_durvalumab_v_lecbe_nemalobunecneho_karcinomu_plic.php weekly 0.7 /magno/xon/2021/mn3.php weekly 0.7 /artkey/xon-202103-0012_epidemie_v_8239_oboru_gynekologicka_onkologie.php weekly 0.7 /artkey/xon-202103-0007_vyznam_pohybove_aktivity_u_onkologickych_pacientu_a_jeji_vliv_na_prevenci_vzniku_nadorovych_onemocneni.php weekly 0.7 /artkey/xon-202103-0008_vismodegib_v_lecbe_recidivujiciho_lokalne_pokrocileho_bazocelularniho_karcinomu.php weekly 0.7 /artkey/xon-202103-0009_alk_rizeny_nemalobunecny_karcinom_plic_-_prevence_profylaxe_a_lecba_mozkovych_metastaz.php weekly 0.7 /artkey/xon-202103-0001_imunoterapie_v_gynekologicke_onkologii.php weekly 0.7 /artkey/xon-202103-0002_postaveni_roboticke_chirurgie_v_managementu_casneho_cervikalniho_karcinomu.php weekly 0.7 /artkey/xon-202103-0003_panevni_exenterace_-_onkogynekologicka_operace.php weekly 0.7 /artkey/xon-202103-0004_nove_moznosti_lecby_u_karcinomu_delozniho_hrdla.php weekly 0.7 /artkey/xon-202103-0005_problematika_chirurgickych_vykonu_u_obeznich_a_morbidne_obeznich_pacientek_v_gynekologicke_onkologii.php weekly 0.7 /artkey/xon-202103-0006_paliativni_chirurgicke_a_intervencni_vykony_u_vybranych_stavu_v_onkogynekologii.php weekly 0.7 /artkey/xon-202103-0011_specifika_pristupu_k_onkologickym_pacientum_s_demenci.php weekly 0.7 /artkey/xon-202103-0010_farmakologicky_profil_-_emicizumab.php weekly 0.7 /magno/xon/2021/mn4.php weekly 0.7 /artkey/xon-202104-0001_melanom_a_jeho_lecba.php weekly 0.7 /artkey/xon-202104-0007_onivyde_-_nova_lecba_pro_delsi_celkove_preziti_pacientu_s_metastatickym_karcinomem_pankreatu.php weekly 0.7 /artkey/xon-202104-0008_mogamulizumab_nova_lecba_pokrocilych_stadii_koznich_t_bunecnych_lymfomu_-_mycosis_fungoides_a_sezaryho_syndrom.php weekly 0.7 /artkey/xon-202104-0009_endosonograficky_navigovana_gastroenteroanastomoza_jako_reseni_maligni_obstrukce_vyvodne_casti_traviciho_traktu.php weekly 0.7 /artkey/xon-202104-0002_adjuvantni_lecba_maligniho_melanomu_obecne_a_prakticke_zkusenosti.php weekly 0.7 /artkey/xon-202104-0003_pokroky_v_systemove_lecbe_mozkovych_metastaz_u_maligniho_melanomu.php weekly 0.7 /artkey/xon-202104-0004_kozni_toxicita_braf_a_mek_inhibitoru.php weekly 0.7 /artkey/xon-202104-0005_sekvencni_lecba_u_metastatickeho_braf_v600_mutovaneho_melanomu_stale_otevrene_otazky_bez_jasnych_odpovedi.php weekly 0.7 /artkey/xon-202104-0006_kazuistika_pacienta_s_metastazujicim_melanomem_leceneho_nekolika_liniemi_systemove_lecby.php weekly 0.7 /artkey/xon-202104-0010_vyuziti_metody_fmea_v_rizeni_rizik_ve_zdravotnictvi.php weekly 0.7 /artkey/xon-202104-0011_kazuistika_pacienta_s_generalizovanym_ca_prostaty_leceneho_pripravkem_jevtana_s_prednisonem_-_4_rada_systemove.php weekly 0.7 /magno/xon/2021/mn5.php weekly 0.7 /artkey/xon-202105-0010_neuroonkologie_soucasnosti.php weekly 0.7 /artkey/xon-202105-0007_fytofarmaka_v_onkologicke_lecbe_-_1_dil.php weekly 0.7 /artkey/xon-202105-0008_dosazeni_kompletni_remise_a_dlouhodoba_lecebna_odpoved_pri_kombinaci_gemcitabin_nab-paclitaxel_u_pacienta_s_g.php weekly 0.7 /artkey/xon-202105-0001_chirurgicka_lecba_gliomu_mozku.php weekly 0.7 /artkey/xon-202105-0002_awake_kraniotomie_aneb_kousek_vedy_kousek_zrucnosti_kousek_empatie_a_hodne_pacientovy_odvahy.php weekly 0.7 /artkey/xon-202105-0003_terapie_adenomu_hypofyzy_-_moznosti_chirurgicke_lecby.php weekly 0.7 /artkey/xon-202105-0004_chirurgicka_lecba_meningeomu.php weekly 0.7 /artkey/xon-202105-0005_chirurgicka_terapie_mozkovych_metastaz.php weekly 0.7 /artkey/xon-202105-0006_nadory_paterniho_kanalu.php weekly 0.7 /artkey/xon-202105-0009_vztah_medzi_spiritualnymi_potrebami_a_kvalitou_zivota_pacientok_s_karcinomom_prsnika.php weekly 0.7 /magno/xon/2021/mn6.php weekly 0.7 /artkey/xon-202106-0011_karcinom_plic_8211_svitani_nad_vodami.php weekly 0.7 /artkey/xon-202106-0006_moznosti_fytofarmak_v_prevenci_a_terapii_komplikaci_protinadorove_lecby_-_2_dil.php weekly 0.7 /artkey/xon-202106-0007_gastrointestinalny_stromalny_tumor_s_viacnasobnou_mutaciou_c-kit_genu_po_liecbe_inhibitormi_tyrozinovych_kinaz.php weekly 0.7 /artkey/xon-202106-0008_kazuistika_-_diseminovany_karcinom_endometria.php weekly 0.7 /artkey/xon-202106-0009_primarni_angiosarkom_prsu.php weekly 0.7 /artkey/xon-202106-0010_cemiplimab_v_lecbe_metastatickeho_spinocelularniho_karcinomu.php weekly 0.7 /artkey/xon-202106-0001_vyznam_a_prinos_vysetrovani_cirkulujici_nadorove_dna_pro_diagnostiku_a_terapii_nemalobunecnych_karcinomu_plic.php weekly 0.7 /artkey/xon-202106-0002_moznosti_lecby_nemalobunecneho_plicniho_karcinomu_stadia_iii.php weekly 0.7 /artkey/xon-202106-0003_vyhledavani_a_management_casnych_stadii_karcinomu_plic.php weekly 0.7 /artkey/xon-202106-0004_nsclc_nemalobunecny_plicni_karcinom_a_tumor_ledviny_u_starsiho_pacienta_s_odpovedi_na_chemoimunoterapii.php weekly 0.7 /artkey/xon-202106-0005_doporucit_nekurte_nestaci.php weekly 0.7 /magno/xon/2020/mn1.php weekly 0.7 /artkey/xon-202001-0012_onkologicka_onemocneni_u_8239_geriatrickych_pacientu.php weekly 0.7 /artkey/xon-202001-0005_novinky_v_8239_lecbe_metastatickeho_karcinomu_ledviny.php weekly 0.7 /artkey/xon-202001-0006_klinicky_vyznam_her-3_u_8239_karcinomu_prsu.php weekly 0.7 /artkey/xon-202001-0008_soucasny_pohled_na_lecbu_pokrocileho_adenokarcinomu_slinivky_brisni.php weekly 0.7 /artkey/xon-202001-0009_systemova_lecba_metastazujiciho_uvealniho_melanomu_anti-pd-1_protilatkami.php weekly 0.7 /artkey/xon-202001-0010_zevni_rizikove_faktory_vzniku_karcinomu_plic_u_8239_nekuraku.php weekly 0.7 /artkey/xon-202001-0011_hormonalni_lecba_karcinomu_prostaty_a_8239_kardiovaskularni_onemocneni.php weekly 0.7 /artkey/xon-202001-0001_senior_s_8239_onkologickym_onemocnenim.php weekly 0.7 /artkey/xon-202001-0002_moznosti_komplexniho_klinickeho_hodnoceni_starsiho_onkologickeho_nemocneho.php weekly 0.7 /artkey/xon-202001-0003_infarkt_myokardu_jako_klinicky_stav_manifestujici_zhoubny_nador_mocoveho_mechyre.php weekly 0.7 /artkey/xon-202001-0004_atypicka_incialni_symptomatologie_tumoru_pankreatu.php weekly 0.7 /artkey/xon-202001-0014_trifluridin_tipiracil_ve_3_linii_lecby_kolorektalniho_karcinomu_a_8239_nove_i_8239_karcinomu_zaludku.php weekly 0.7 /artkey/xon-202001-0015_polatuzumab_vedotin_8211_nova_nadeje_pro_pacienty_s_8239_relabujicim_remitentnim_velkobunecnym_b_lymfomem.php weekly 0.7 /artkey/xon-202001-0016_her2-pozitivni_casny_karcinom_prsu_8211_na_ceste_k_8239_uplnemu_vyleceni.php weekly 0.7 /artkey/xon-202001-0013_odesel_velky_clovek_a_8239_lekar_prof_mudr_vitezslav_kolek_drsc_fccp.php weekly 0.7 /magno/xon/2020/mn2.php weekly 0.7 /artkey/xon-202002-0009_fetomaternalni_onkologie_8211_novy_podobor.php weekly 0.7 /artkey/xon-202002-0005_uskali_laboratornich_metod_v_ovarialnim_skrininku_-_doba_-omicka.php weekly 0.7 /artkey/xon-202002-0006_rezidualni_nemoc_po_neoadjuvantni_systemove_anti_her2_lecbe_-_studie_katherine.php weekly 0.7 /artkey/xon-202002-0007_vybrane_caste_specialni_paliativni_postupy_u_nsclc.php weekly 0.7 /artkey/xon-202002-0001_epidemiologie_a_prognoza_zhoubnych_nadoru_v_tehotenstvi.php weekly 0.7 /artkey/xon-202002-0002_diagnostika_a_staging_nadorovych_onemocneni_v_tehotenstvi.php weekly 0.7 /artkey/xon-202002-0003_onkologicka_lecba_v_tehotenstvi.php weekly 0.7 /artkey/xon-202002-0004_perinatologicky_management_a_follow-up_deti_vystavenych_protinadorove_lecbe_in_utero.php weekly 0.7 /artkey/xon-202002-0008_uskali_osetrovatelske_pece_o_pacientky_s_permanentnim_mocovym_katetrem_po_radikalni_onkogynekologicke_operaci_v.php weekly 0.7 /magno/xon/2020/mn3.php weekly 0.7 /artkey/xon-202003-0001_inflamatorni_lymfomy.php weekly 0.7 /artkey/xon-202003-0006_soucasny_pohled_na_lecbu_pokrocileho_metastatickeho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-202003-0002_aktualni_pohled_na_diagnostiku_a_lecbu_primarnich_lymfomu_centralniho_nervoveho_systemu.php weekly 0.7 /artkey/xon-202003-0003_primarni_mediastinalni_b-velkobunecny_lymfom_prinos_pozitronove_emisni_tomografie.php weekly 0.7 /artkey/xon-202003-0004_primarni_mediastinalni_velkobunecny_b-lymfom_vyznam_genetickych_zmen.php weekly 0.7 /artkey/xon-202003-0005_volna_nadorova_dna_u_pacientov_s_hodgkinovym_lymfomom.php weekly 0.7 /artkey/xon-202003-0007_nivolumab_v_terapii_rekurentnich_ci_metastazujicich_nadoru_hlavy_a_krku.php weekly 0.7 /magno/xon/2020/mn4.php weekly 0.7 /artkey/xon-202004-0010_karcinom_prsu_epidemiologie_moznosti_a_8239_novinky_v_8239_diagnosticko_lecebnem_programu.php weekly 0.7 /artkey/xon-202004-0006_moznosti_vyuziti_novych_primych_oralnich_antikoagulancii_v_onkologii.php weekly 0.7 /artkey/xon-202004-0007_moznosti_precizni_mediciny_v_klinicke_praxi_onkologa.php weekly 0.7 /artkey/xon-202004-0008_novinky_v_lecbe_karcinomu_stitne_zlazy_-_pohled_endokrinologa.php weekly 0.7 /artkey/xon-202004-0001_epidemiologie_novotvaru_prsu_v_dobe_organizovaneho_screeningoveho_programu_v_ceske_republice.php weekly 0.7 /artkey/xon-202004-0002_komplexni_lecba_casneho_karcinomu_prsu.php weekly 0.7 /artkey/xon-202004-0003_postaveni_protonove_radioterapie_v_komplexnim_diagnosticko_lecebnem_programu_karcinomu_prsu.php weekly 0.7 /artkey/xon-202004-0004_karcinom_prsu_u_muzu_-_porovnani_literarnich_udaju_s_vlastnim_materialem_a_udaji_nor.php weekly 0.7 /artkey/xon-202004-0005_karcinom_prsu_u_muze_-_pozdni_diseminace_do_skeletu.php weekly 0.7 /artkey/xon-202004-0009_trauma-informovany_pristup_v_paliativni_osetrovatelske_peci_o_onkologicky_nemocne.php weekly 0.7 /magno/xon/2020/mn5.php weekly 0.7 /artkey/xon-202005-0010_imunoterapie_v_8239_onkologii.php weekly 0.7 /artkey/xon-202005-0006_gastrointestinalni_stromalni_nador_-_novinky_v_lecbe.php weekly 0.7 /artkey/xon-202005-0007_nemelanomove_kozni_nadory.php weekly 0.7 /artkey/xon-202005-0008_perioperacni_lecba_lokalne_pokrocileho_karcinomu_zaludku.php weekly 0.7 /artkey/xon-202005-0009_zdravotna_gramotnost_pacientov_s_onkologickym_ochorenim_literarna_prehladova_studia.php weekly 0.7 /artkey/xon-202005-0001_realne_dostupne_novinky_v_imunoterapii_pohledem_klinickeho_onkologa_pracujiciho_v_cr.php weekly 0.7 /artkey/xon-202005-0002_imunitni_biomarkery_pro_predikci_odpovedi_na_lecbu_checkpoint_inhibitory.php weekly 0.7 /artkey/xon-202005-0003_kombinovana_lecba_radioterapie_s_checkpoint_inhibitory.php weekly 0.7 /artkey/xon-202005-0004_vyuziti_imunoterapie_v_neoadjuvanci.php weekly 0.7 /artkey/xon-202005-0005_imunoterapie_v_lecbe_klasickeho_hodgkinova_lymfomu.php weekly 0.7 /magno/xon/2020/mn6.php weekly 0.7 /artkey/xon-202006-0010_lecba_nadoru_tlusteho_streva_8211_kterym_smerem_je_budoucnost.php weekly 0.7 /artkey/xon-202006-0004_paliativni_radioterapie_v_managementu_symptomu_pokrocileho_onkologickeho_onemocneni.php weekly 0.7 /artkey/xon-202006-0005_moznosti_nenadorove_zevni_radioterapie.php weekly 0.7 /artkey/xon-202006-0006_fyzioterapie_jako_soucast_komplexni_lecby_zen_po_operaci_prsu.php weekly 0.7 /artkey/xon-202006-0007_transarterialni_chemoembolizace_jako_paliativni_reseni_primarnich_a_sekundarnich_nadoru_jater_-_soubor_fn_plzen.php weekly 0.7 /artkey/xon-202006-0001_terapie_metastatickeho_kolorektalniho_karcinomu_v_roce_2020.php weekly 0.7 /artkey/xon-202006-0002_sekvence_vegf_r_preparatu_v_lecbe_metastatickeho_karcinomu_kolon_v_roce_2020.php weekly 0.7 /artkey/xon-202006-0003_neoadjuvantni_lecba_u_karcinomu_rekta.php weekly 0.7 /artkey/xon-202006-0008_role_sestry_v_psychosocialni_podpore_prarodicu_onkologicky_nemocnych_deti.php weekly 0.7 /artkey/xon-202006-0009_targeting_mutated_isocitric_dehydrogenase_1_midh_1_in_acute_myeloid_leukemia_aml_story_of_ivosidenib.php weekly 0.7 /magno/xon/2020/mn88.php weekly 0.7 /artkey/xon-202088-0005_proc_psat_kazuistiku.php weekly 0.7 /artkey/xon-202088-0001_nahodny_nalez_dilatace_pankreatickeho_vyvodu_jako_priznak_asymptomatickeho_karcinomu_pankreatu.php weekly 0.7 /artkey/xon-202088-0002_pembrolizumab_v_lecbe_82lete_pacientky_s_nsclc.php weekly 0.7 /artkey/xon-202088-0003_objemny_exulcerovany_adenomyoepiteliom_prsu.php weekly 0.7 /artkey/xon-202088-0004_zavazne_komplikace_u_pacienta_s_generalizovanym_nemalobunecnym_plicnim_karcinomem_leceneho_pembrolizumabem.php weekly 0.7 /magno/xon/2020/mn89.php weekly 0.7 /artkey/xon-202089-0001_proc_a_jak_psat_kazuistiku.php weekly 0.7 /artkey/xon-202089-0002_izolovana_axilarni_lymfadenopatie_jako_prvni_projev_dlazdicobunecneho_karcinomu_vulvy.php weekly 0.7 /artkey/xon-202089-0003_nivolumabem_indukovana_hepatitida_u_pacientky_lecene_pro_maligni_melanom.php weekly 0.7 /artkey/xon-202089-0004_kazuistika_vyrazne_regrese_lecby_nsclc_pri_lecbe_pembrolizumabem_v_monoterapii.php weekly 0.7 /artkey/xon-202089-0005_kdyz_ani_ctyri_alk_inhibitory_nestaci.php weekly 0.7 /artkey/xon-202089-0006_pacient_s_generalizovanym_malignim_melanomem_leceny_pembrolizumabem.php weekly 0.7 /artkey/xon-202089-0007_imunoterapie_-_nova_nadeje_i_pro_pacienty_s_prognosticky_nepriznivym_histologickym_typem_karcinomu_plic.php weekly 0.7 /artkey/xon-202089-0008_terapie_mlade_dospele_pacientky_s_pineoblastomem_protonovou_terapii_a_vysokodavkovanou_chemoterapii_po_neurochi.php weekly 0.7 /magno/xon/2020/mn90.php weekly 0.7 /artkey/xon-202090-0001_proc_psat_kazuistiku_ocima_mladeho_onkologa.php weekly 0.7 /artkey/xon-202090-0002_dlouhodoba_lecebna_odpoved_u_pacientky_s_generalizovanym_kolorektalnim_karcinomem_lecene_chemoterapii_triflurid.php weekly 0.7 /artkey/xon-202090-0003_epiteloidni_sarkom_vulvy_proximalni_typ.php weekly 0.7 /artkey/xon-202090-0004_kazuistika_pacientky_s_metastatickym_nemalobunecnym_karcinomem_plic_s_pozitivni_prestavbou_genu_alk_lecene_v_1.php weekly 0.7 /artkey/xon-202090-0005_vyuziti_radioterapie_v_lecbe_pooperacniho_chylozniho_ascitu.php weekly 0.7 /artkey/xon-202090-0006_monoterapie_pembrolizumabem_v_prvni_linii_lecby_u_nemalobunecneho_karcinomu_plic_s_vysokou_expresi_pd-l1_ge.php weekly 0.7 /artkey/xon-202090-0007_pacient_s_nadorem_neznameho_primarniho_origa_-_lecba_a_prubeh_onemocneni.php weekly 0.7 /artkey/xon-202090-0008_pripad_znacne_pokrocileho_metastatickeho_braf-mutovaneho_maligniho_melanomu_leceneho_pembrolizumabem_s_vybornou.php weekly 0.7 /artkey/xon-202090-0009_imunoterapie_pokrocileho_plicniho_a_duplicitniho_urotelialniho_karcinomu_-_prvni_zkusenosti.php weekly 0.7 /artkey/xon-202090-0010_lecba_pacientky_s_diferencovanym_karcinomem_stitnice.php weekly 0.7 /magno/xon/2020/mn91.php weekly 0.7 /artkey/xon-202091-0008_zrnka_pozitiv_v_8239_narocnych_prozitcich.php weekly 0.7 /artkey/xon-202091-0001_jak_zvladnout_nezadouci_ucinky_imunoterapie.php weekly 0.7 /artkey/xon-202091-0002_nezadouci_ucinky_chemoterapie.php weekly 0.7 /artkey/xon-202091-0003_jak_zvladnout_nezadouci_ucinky_cilene_lecby_solidnich_nadoru.php weekly 0.7 /artkey/xon-202091-0004_jak_zvladnout_nezadouci_ucinky_radioterapie.php weekly 0.7 /artkey/xon-202091-0005_kozni_nezadouci_ucinky_protinadorove_lecby.php weekly 0.7 /artkey/xon-202091-0006_jak_pristupovat_k_nechutenstvi_a_vyzive_u_paliativnich_pacientu.php weekly 0.7 /artkey/xon-202091-0007_sdelovani_spatnych_zprav_pacientum_a_narocna_komunikace_v_onkologicke_praxi.php weekly 0.7 /magno/xon/2020/mn92.php weekly 0.7 /artkey/xon-202092-0001_karcinom_prsu_a_chirurgicka_lecba_v_cechach_a_na_morave.php weekly 0.7 /artkey/xon-202092-0002_karcinom_prsu_u_muzu.php weekly 0.7 /artkey/xon-202092-0003_pagetuv_karcinom_prsu_a_karcinom_mocoveho_mechyre_u_muze_-_raritni_synchronni_nadorova_duplicita.php weekly 0.7 /artkey/xon-202092-0004_pacientka_s_metastazujicim_melanomem_dlouhodobe_prezivajici_po_terapii_pembrolizumabem_ve_3_linii_lecby.php weekly 0.7 /artkey/xon-202092-0005_kazuistika_mladeho_pacienta_s_masivne_diseminovanym_malignim_melanomem_leceneho_cilenou_lecbou.php weekly 0.7 /artkey/xon-202092-0006_autoimunitne_i_neautoimunitne_podminene_komplikace_uspesne_lecby_karcinomu_plic_pembrolizumabem.php weekly 0.7 /artkey/xon-202092-0007_casna_diseminace_do_skeletu_u_pacienta_s_lokalne_pokrocilym_adenokarcinomem_rekta_po_neoadjuvantni_chemoradiote.php weekly 0.7 /artkey/xon-202092-0008_dobre_vysledky_lecby_pembrolizumabem_u_nemocneho_s_duplicitnim_plicnim_karcinomem.php weekly 0.7 /artkey/xon-202092-0009_alectinib_v_lecbe_nsclc.php weekly 0.7 /magno/xon/2020/mn93.php weekly 0.7 /artkey/xon-202093-0001_pembrolizumab_v_kombinaci_s_radioterapii_u_pacienta_s_generalizovanym_melanomem.php weekly 0.7 /artkey/xon-202093-0002_germinalni_nador_cns_uskali_diagnostiky_i_terapie.php weekly 0.7 /artkey/xon-202093-0003_lecba_metastatickeho_karcinomu_ledviny.php weekly 0.7 /artkey/xon-202093-0004_pembrolizumab_v_prvni_linii_lecby_metastatickeho_nemalobunecneho_plicniho_karcinomu.php weekly 0.7 /artkey/xon-202093-0005_dlouhodobe_preziti_u_pacientky_s_generalizovanym_her-2_pozitivnim_hormonalne_independentnim_karcinomem_prsu_-.php weekly 0.7 /artkey/xon-202093-0006_kompletni_odpoved_na_lecbu_pembrolizumabem_u_pacienta_ve_iv_klinickem_stadiu_nsclc.php weekly 0.7 /magno/xon/2020/mn94.php weekly 0.7 /artkey/xon-202094-0001_metastazujici_in_situ_karcinom_cipku_delozniho.php weekly 0.7 /artkey/xon-202094-0002_dlouhodoba_kontrola_generalizovaneho_karcinomu_plic_pembrolizumabem.php weekly 0.7 /artkey/xon-202094-0003_komplexni_karyotyp_u_mladsi_nemocne_s_chronickou_lymfocytarni_leukemii.php weekly 0.7 /artkey/xon-202094-0004_pembrolizumab_v_lecbe_adenokarcinomu_plic_s_malignim_perikardialnim_vypotkem.php weekly 0.7 /artkey/xon-202094-0005_gastrinom_a_jeho_mozne_komplikace.php weekly 0.7 /artkey/xon-202094-0006_dlouhodoba_lecebna_odpoved_a_kompletni_regrese_nemoci_nemocneho_s_nsclc_leceneho_pembrolizumabem_v_monoterapii.php weekly 0.7 /artkey/xon-202094-0007_kutanni_angiosarkom_versus_hematom_pri_antikoagulacni_lecbe.php weekly 0.7 /magno/xon/2019/mn1.php weekly 0.7 /artkey/xon-201901-0001_slovo_uvodem.php weekly 0.7 /artkey/xon-201901-0006_dlazdicobunecny_karcinom_vulvy.php weekly 0.7 /artkey/xon-201901-0007_testikularni_nadory.php weekly 0.7 /artkey/xon-201901-0008_vzdalene_intracerebelarni_krvaceni_po_resekci_tumoru_spankoveho_laloku.php weekly 0.7 /artkey/xon-201901-0002_moznosti_a_uskali_diagnostiky_karcinomu_prsu_u_mladych_zen.php weekly 0.7 /artkey/xon-201901-0003_karcinom_prsu_a_tehotenstvi.php weekly 0.7 /artkey/xon-201901-0004_postaveni_radioterapie_u_mladych_pacientek_s_karcinomem_prsu.php weekly 0.7 /artkey/xon-201901-0005_hormonalni_lecba_u_premenopauzalnich_pacientek_se_sr_pozitivnim_her2_negativnim_karcinomem_prsu.php weekly 0.7 /artkey/xon-201901-0009_jak_dosahnout_u_pacientu_s_mcrc_ve_3_linii_maximalniho_benefitu.php weekly 0.7 /magno/xon/2019/mn2.php weekly 0.7 /artkey/xon-201902-0001_co_to_je_za_nemoc_a_proc_ji_nelecime.php weekly 0.7 /artkey/xon-201902-0004_imunoterapie_karcinomu_prsu.php weekly 0.7 /artkey/xon-201902-0005_upgrade_farmakoterapie_nadorove_bolesti.php weekly 0.7 /artkey/xon-201902-0006_soucasne_klinicke_vyuziti_markeru_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201902-0007_dysfagie_u_pacientu_s_nadory_hlavy_a_krku.php weekly 0.7 /artkey/xon-201902-0008_glioblastom_s_primitivni_neuronalni_komponentou_u_dlouhodobe_prezivajici_pacientky.php weekly 0.7 /artkey/xon-201902-0009_karcinom_ledviny_s_nadorovym_trombem_do_prave_srdecni_sine.php weekly 0.7 /artkey/xon-201902-0002_co_je_noveho_u_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201902-0003_nadory_zazivaciho_traktu_u_deti.php weekly 0.7 /magno/xon/2019/mn3.php weekly 0.7 /artkey/xon-201903-0001_o_psychologicke_podpore_pacientu_s_viditelnymi_dermatozami.php weekly 0.7 /artkey/xon-201903-0005_kostni_metastazy_diagnostika_a_sledovani_na_zobrazovacich_metodach_intervencni_radiologie.php weekly 0.7 /artkey/xon-201903-0006_diagnostika_operacni_a_systemova_terapie_metastaz_solidnich_nadoru.php weekly 0.7 /artkey/xon-201903-0007_difuzni_low_grade_gliomy_8211_jak_je_spravne_diagnostikovat_a_efektivne_lecit.php weekly 0.7 /artkey/xon-201903-0008_smiseny_epitelialni_a_stromalni_nador_ledviny.php weekly 0.7 /artkey/xon-201903-0002_alogenni_transplantace_krvetvornych_bunek_a_bunecna_terapie_u_cll.php weekly 0.7 /artkey/xon-201903-0003_lecba_relabovane_chronicke_lymfocytarni_leukemie.php weekly 0.7 /artkey/xon-201903-0004_pohybovy_a_respiracni_intervencni_program_pro_hematoonkologicke_pacienty.php weekly 0.7 /artkey/xon-201903-0009_potreby_pacienta_s_multiformnym_glioblastomom_kvalitativna_studia.php weekly 0.7 /magno/xon/2019/mn4.php weekly 0.7 /artkey/xon-201904-0001_proc_pacienty_varovat_pred_workoholismem.php weekly 0.7 /artkey/xon-201904-0002_novinky_v_lecbe_hormon-senzitivniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201904-0003_enzalutamid_v_lecbe_metastatickeho_kastracne_rezistentniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201904-0004_faktory_ovlivnujici_prulomovou_bolest.php weekly 0.7 /artkey/xon-201904-0005_soucasne_moznosti_radioterapie_mozkovych_metastaz_solidnich_nadoru.php weekly 0.7 /artkey/xon-201904-0006_budouci_trendy_v_lecbe_karcinomu_jicnu_prevence_biologicka_terapie_imunoterapie_individualizovana_terapie.php weekly 0.7 /artkey/xon-201904-0007_biosimilars_8211_terapeuticka_hodnota_regulacni_aspekty_role_farmaceuta.php weekly 0.7 /artkey/xon-201904-0008_raritny_pripad_embryonalneho_rabdomyosarkomu_v_dospelosti.php weekly 0.7 /magno/xon/2019/mn5.php weekly 0.7 /artkey/xon-201905-0001_soucasne_lecebne_moznosti_urotelialniho_karcinomu.php weekly 0.7 /artkey/xon-201905-0006_role_radiologa_v_peci_o_zenu_s_karcinomem_prsu.php weekly 0.7 /artkey/xon-201905-0007_samotna_chemoterapie_jiz_dnes_neni_standardem_lecby_pokrocileho_nemalobunecneho_karcinomu_plic_nsclc.php weekly 0.7 /artkey/xon-201905-0008_soucasne_moznosti_lecby_nadorove_bolesti.php weekly 0.7 /artkey/xon-201905-0009_prognosticke_a_prediktivni_markery_u_nemalobunecneho_plicniho_karcinomu_nsclc_8211_1_dil.php weekly 0.7 /artkey/xon-201905-0010_dosazeni_kompletni_remise_pri_kombinaci_folfiri_aflibercept_zaltrap_174_u_pacientky_s_karcinomem_kolon_a.php weekly 0.7 /artkey/xon-201905-0002_chirurgicka_lecba_nadoru_mocoveho_mechyre.php weekly 0.7 /artkey/xon-201905-0003_chemoterapie_a_cilena_lecba_karcinomu_mocoveho_mechyre.php weekly 0.7 /artkey/xon-201905-0004_novinky_v_radioterapii_karcinomu_mocoveho_mechyre.php weekly 0.7 /artkey/xon-201905-0005_imunoterapie_urotelialnich_karcinomu.php weekly 0.7 /magno/xon/2019/mn6.php weekly 0.7 /artkey/xon-201906-0001_slovo_uvodem.php weekly 0.7 /artkey/xon-201906-0005_neoadjuvantni_lecba_casneho_karcinomu_prsu.php weekly 0.7 /artkey/xon-201906-0006_imunoterapie_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-201906-0007_jak_kdy_a_proc_hodnotit_lecebnou_odpoved_na_lecbu_imunoterapii_8222_check_point_inhibitory_8220_pri_lecbe.php weekly 0.7 /artkey/xon-201906-0008_imunoterapie_u_pacientu_s_mozkovymi_metastazami.php weekly 0.7 /artkey/xon-201906-0009_prognosticke_a_prediktivni_markery_u_nemalobunecneho_plicniho_karcinomu_nsclc_8211_2_dil.php weekly 0.7 /artkey/xon-201906-0010_nadorova_duplicita_v_intramamarni_uzline.php weekly 0.7 /artkey/xon-201906-0002_adaptivni_radioterapie_u_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-201906-0003_abskopalni_efekt_po_stereotakticke_radioterapii_pristrojem_cyberknife.php weekly 0.7 /artkey/xon-201906-0004_kardialni_toxicita_radioterapie.php weekly 0.7 /artkey/xon-201906-0011_plicni_rochada_aneb_drzte_nemoci_plic_v_sachu.php weekly 0.7 /magno/xon/2018/mn1.php weekly 0.7 /artkey/xon-201801-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201801-0006_Onkofertilita_8211_perspektivy_a_komplikace.php weekly 0.7 /artkey/xon-201801-0007_Vyznam_L1CAM_jako_prognostickeho_faktoru_u_karcinomu_endometria.php weekly 0.7 /artkey/xon-201801-0008_Axitinib_ve_druhe_linii_lecby_metastatickeho_renalniho_karcinomu.php weekly 0.7 /artkey/xon-201801-0009_High-grade_gangliogliom_jako_sekundarni_glioneuralni_nador_mozku_u_mladeho_dospeleho.php weekly 0.7 /artkey/xon-201801-0002_Postaveni_FDG_PET_CT_v_managementu_maligniho_melanomu.php weekly 0.7 /artkey/xon-201801-0003_Pokrok_v_lecbe_mozkovych_metastaz_u_pokrocileho_melanomu.php weekly 0.7 /artkey/xon-201801-0004_Agresivni_chovani_nizce_rizikoveho_melanomu_vulvy_8211_od_excize_po_totalni_exenteraci_panve.php weekly 0.7 /artkey/xon-201801-0005_Kompletni_lecebna_odpoved_po_anti-PD1_terapii_u_pacientky_s_pokrocilym_melanomem_a_rezistenci_na_cilenou_terapi.php weekly 0.7 /artkey/xon-201801-0010_Uloha_sestry_v_osetrovatelske_peci_o_dite_behem_chemoterapie.php weekly 0.7 /magno/xon/2018/mn2.php weekly 0.7 /artkey/xon-201802-0001_Fenomen_nasili_ve_zdravotnictvi.php weekly 0.7 /artkey/xon-201802-0002_Prekurzorove_leze_adenokarcinomu_zaludku.php weekly 0.7 /artkey/xon-201802-0003_Brachyterapie_karcinomu_prostaty_ve_svetle_novych_doporuceni.php weekly 0.7 /artkey/xon-201802-0004_Karcinom_mlecne_zlazy.php weekly 0.7 /artkey/xon-201802-0005_Diagnostika_a_lecba_ampulomu.php weekly 0.7 /artkey/xon-201802-0006_Neoadjuvantna_chemoterapia_pokrocileho_epitelialneho_ovarialneho_karcinomu.php weekly 0.7 /artkey/xon-201802-0008_Velice_dobry_efekt_eskalace_systemove_paliativni_chemoterapie_u_generalizovaneho_karcinomu_pankreatu.php weekly 0.7 /artkey/xon-201802-0007_Vlastni_zkusenost_s_axitinibem_v_lecbe_metastatickeho_karcinomu_ledviny.php weekly 0.7 /magno/xon/2018/mn3.php weekly 0.7 /artkey/xon-201803-0001_Diagnostika_a_lecba_koznich_lymfomu_v_Ceske_republice_v_roce_2018.php weekly 0.7 /artkey/xon-201803-0008_Lecba_nemocne_s_opakovane_relabovanou_chronickou_lymfocytarni_leukemii.php weekly 0.7 /artkey/xon-201803-0009_Germinalni_nadory_CNS_8211_2_kazuistiky.php weekly 0.7 /artkey/xon-201803-0002_Epidemiologie_primarnich_koznich_lymfomu_v_Ceske_republice_podle_dat_Narodniho_onkologickeho_registru_z_let_200.php weekly 0.7 /artkey/xon-201803-0003_Uskali_diagnostiky_koznich_lymfomu_z_pohledu_patologa.php weekly 0.7 /artkey/xon-201803-0004_Primarni_kozni_lymfomy_v_dermatologicke_praxi.php weekly 0.7 /artkey/xon-201803-0005_Role_hematologa_v_multidisciplinarni_peci_o_nemocne_s_koznim_lymfomem.php weekly 0.7 /artkey/xon-201803-0006_Brentuximab_vedotin_v_lecbe_relabujicich_CD30_koznich_lymfomu_8211_vysledky_mezinarodni_randomizovane_klini.php weekly 0.7 /artkey/xon-201803-0007_CyberKnife_v_lecbe_metastaz_mozku.php weekly 0.7 /magno/xon/2018/mn4.php weekly 0.7 /artkey/xon-201804-0001_Nemalobunecny_karcinom_plic_8211_pokroky_v_lecbe.php weekly 0.7 /artkey/xon-201804-0008_Mozny_vliv_psychologickych_faktoru_na_progresi_onkologickeho_onemocneni.php weekly 0.7 /artkey/xon-201804-0009_Bevacizumab_v_liecbe_epitelialneho_karcinomu_vajecnikov_efektivita_a_rizika.php weekly 0.7 /artkey/xon-201804-0010_Nab-paklitaxel_u_dlouhodobe_lecene_pacientky_s_metastatickym_karcinomem_pankreatu.php weekly 0.7 /artkey/xon-201804-0002_Pokroky_v_radioterapii_karcinomu_plic.php weekly 0.7 /artkey/xon-201804-0003_Aktualni_moznosti_lecby_skvamozniho_karcinomu_plic.php weekly 0.7 /artkey/xon-201804-0004_Adjuvantni_chemoterapie_u_nemalobunecneho_karcinomu_plic_8211_jak_se_vyuziva_v_praxi.php weekly 0.7 /artkey/xon-201804-0005_Lecba_nemocnych_s_nemalobunecnym_karcinomem_a_mutacemi_genu_receptoru_epidermalniho_rustoveho_faktoru.php weekly 0.7 /artkey/xon-201804-0006_Lecba_nemocnych_s_nemalobunecnym_plicnim_karcinomem_s_prestavbou_genu_ALK.php weekly 0.7 /artkey/xon-201804-0007_Postaveni_imunoterapie_v_lecbe_nemalobunecneho_karcinomu_plic.php weekly 0.7 /magno/xon/2018/mn5.php weekly 0.7 /artkey/xon-201805-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201805-0005_Antiangiogenni_lecba_karcinomu_plic.php weekly 0.7 /artkey/xon-201805-0006_Posuzovani_zdravotniho_stavu_pro_ucely_davek_a_sluzeb_socialniho_zabezpeceni_u_osob_s_karcinomem_prsu.php weekly 0.7 /artkey/xon-201805-0007_Antiemeticka_lecba_u_onkologicky_nemocnych.php weekly 0.7 /artkey/xon-201805-0002_Mame_nove_moznosti_v_nechirurgicke_lecbe_lokalne_pokrocileho_a_vysoce_rizikoveho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201805-0003_Nasli_jsme_optimalni_sekvenci_v_lecbe_metastatickeho_kastracne_rezistentniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201805-0004_Je_vek_limitaci_lecby_metastatickeho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201805-0008_manazment_fyzickych_symptomov_u_pacienta_s_multiformnym_glioblastomom_z_pohladu_sestry.php weekly 0.7 /magno/xon/2018/mn6.php weekly 0.7 /artkey/xon-201806-0001_At_zijou_mikrouti.php weekly 0.7 /artkey/xon-201806-0002_Novinky_v_systemove_lecbe_pokrocileho_a_metastatickeho_karcinomu_zaludku.php weekly 0.7 /artkey/xon-201806-0003_karcinom_prsu_ve_vyssim_veku.php weekly 0.7 /artkey/xon-201806-0004_Fertilitu_setrici_lecba_u_zen_s_karcinomem_endometria_a_ovaria.php weekly 0.7 /artkey/xon-201806-0005_Anemie_u_onkologickych_pacientu_8211_diagnostika_a_lecba.php weekly 0.7 /artkey/xon-201806-0006_Nejcastejsi_lekove_interakce_u_protinadorovych_leciv.php weekly 0.7 /artkey/xon-201806-0007_Dopady_liecby_genitourinarnych_malignit_na_kardiovaskularny_system.php weekly 0.7 /artkey/xon-201806-0008_Celiakie_8211_diagnostika_lecba_rizika_rozvoje_malignity.php weekly 0.7 /artkey/xon-201806-0009_Jak_pristupovat_k_biosimilar_pripravkum_v_lecbe_onkologickych_pacientu.php weekly 0.7 /magno/xon/2018/mn88.php weekly 0.7 /artkey/xon-201888-0001_HOSPICOVA_A_PALIATIVNI_PECE.php weekly 0.7 /magno/xon/2017/mn1.php weekly 0.7 /artkey/xon-201701-0001_Nadory_ledvin.php weekly 0.7 /artkey/xon-201701-0005_Pokrocily_metastaticky_kastracne_rezistentni_karcinom_prostaty_mCRPC_v_souladu_s_lecbou_ARTA_androgen_recept.php weekly 0.7 /artkey/xon-201701-0006_Vyziva_a_nadorove_onemocneni.php weekly 0.7 /artkey/xon-201701-0007_Racionalni_vyuziti_psychofarmak_v_onkologii_8211_vybrane_indikace_interakce_tipy_pro_praxi.php weekly 0.7 /artkey/xon-201701-0008_Uvealni_melanom.php weekly 0.7 /artkey/xon-201701-0009_Metastaza_maligniho_melanomu_jako_pricina_obstrukce_gastrointestinalniho_traktu.php weekly 0.7 /artkey/xon-201701-0010_karcinom_prsu_chronicke_onemocneni_8211_anti_her2_terapie.php weekly 0.7 /artkey/xon-201701-0002_Renesance_imunoterapie_v_lecbe_nadoru_ledvin.php weekly 0.7 /artkey/xon-201701-0003_Sunitinib_v_adjuvantni_terapii_renalniho_karcinomu.php weekly 0.7 /artkey/xon-201701-0004_Novinky_v_chirurgicke_lecbe_nadoru_ledvin.php weekly 0.7 /magno/xon/2017/mn2.php weekly 0.7 /artkey/xon-201702-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201702-0005_Osimertinib_8211_nova_volba_lecby_pro_pacienty_s_mutaci_EGFR_T790M.php weekly 0.7 /artkey/xon-201702-0006_Systemova_terapie_v_lecbe_karcinomu_delozniho_hrdla.php weekly 0.7 /artkey/xon-201702-0007_Toxicita_imunoterapie.php weekly 0.7 /artkey/xon-201702-0009_Kazuistika_pacienta_s_metastazujicim_malignim_melanomem_lecenym_pembrolizumabem.php weekly 0.7 /artkey/xon-201702-0010_lecba_mcrc_u_62leteho_muze_8211_vyznam_mezioborove_spoluprace.php weekly 0.7 /artkey/xon-201702-0002_Moderni_trendy_v_chirurgii_kolorektalniho_karcinomu_aneb_co_by_mel_onkolog_vedet_o_praci_chirurga.php weekly 0.7 /artkey/xon-201702-0003_Vyznam_magneticke_rezonance_u_nadoru_rekta.php weekly 0.7 /artkey/xon-201702-0004_Anti-EGFR_lecba_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201702-0008_Trifluridin_tipiracil_v_lecbe_pacientu_s_refrakternim_metastatickym_kolorektalnim_karcinomem_8211_prvni_klin.php weekly 0.7 /magno/xon/2017/mn3.php weekly 0.7 /artkey/xon-201703-0001_slovo_uvodem.php weekly 0.7 /artkey/xon-201703-0007_Maligni_melanom_incidence_rizikove_faktory_a_jeho_casna_diagnostika.php weekly 0.7 /artkey/xon-201703-0008_Thymomy_a_karcinomy_thymu.php weekly 0.7 /artkey/xon-201703-0009_Refrakterni_lymfom_z_plastove_zony_u_starsiho_nemocneho_8211_popis_pripadu.php weekly 0.7 /artkey/xon-201703-0002_Lecba_starsich_a_komorbidnich_nemocnych_s_chronickou_lymfocytarni_leukemii.php weekly 0.7 /artkey/xon-201703-0003_Akutni_myeloidni_leukemie_po_predchozi_protinadorove_lecbe.php weekly 0.7 /artkey/xon-201703-0004_Hodgkinuv_lymfom_seniorskeho_veku.php weekly 0.7 /artkey/xon-201703-0005_Ne-Hodgkinovy_lymfomy_v_seniorskem_veku.php weekly 0.7 /artkey/xon-201703-0006_Chronicka_myeloidni_leukemie_8211_studie_bosutinib_v_druhe_linii_lecby_4lete_sledovani.php weekly 0.7 /magno/xon/2017/mn4.php weekly 0.7 /artkey/xon-201704-0001_Rakovina_8211_nemoc_cele_rodiny.php weekly 0.7 /artkey/xon-201704-0008_Moznosti_intervence_vybranych_gastrointestinalnich_potizi_provazejicich_onkologicka_onemocneni.php weekly 0.7 /artkey/xon-201704-0009_Soucasne_moznosti_lecby_metastatickeho_kastracne_rezistentniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201704-0010_Fyzioterapie_u_pacientky_po_ablaci_prsu.php weekly 0.7 /artkey/xon-201704-0002_Slovo_uvodem_k_hlavnimu_tematu_8211_Pristupy_k_lecbe_karcinomu_prsu.php weekly 0.7 /artkey/xon-201704-0003_Moznosti_prekonani_endokrinni_rezistence_u_pokrocileho_karcinomu_prsu_s_pozitivnimi_hormonalnimi_receptory_a_s.php weekly 0.7 /artkey/xon-201704-0004_Nejnovejsi_nazory_na_lecebne_postupy_u_lobularniho_in_situ_karcinomu_LCIS_a_duktalniho_in_situ_karcinomu_DCI.php weekly 0.7 /artkey/xon-201704-0005_nejnovejsi_nazory_na_adjuvantni_radiacni_lecbu_nepokrocileho_karcinomu_prsu.php weekly 0.7 /artkey/xon-201704-0006_Lecebne_postupy_u_karcinomu_prsu_s_HER2_pozitivitou_moznosti_eskalace_a_deeskalace_lecby.php weekly 0.7 /artkey/xon-201704-0007_perspektivni_lecebne_postupy_u_triple_negativniho_karcinomu_prsu.php weekly 0.7 /magno/xon/2017/mn5.php weekly 0.7 /artkey/xon-201705-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201705-0009_Novinky_v_hormonalni_lecbe_karcinomu_prsu.php weekly 0.7 /artkey/xon-201705-0010_Vyuziti_bevacizumabu_Avastin_v_lecbe_recidivujiciho_karcinomu_delozniho_hrdla.php weekly 0.7 /artkey/xon-201705-0002_Role_hypertermicke_intraperitonealni_chemoterapie_v_lecbe_pokrocileho_a_recidivujiciho_ovarialniho_karcinomu.php weekly 0.7 /artkey/xon-201705-0003_Klinicky_vyznam_C-reaktivniho_proteinu_v_onkogynekologii.php weekly 0.7 /artkey/xon-201705-0004_Pece_o_nosicky_mutaci_genu_BRCA1_a_BRCA2_z_hlediska_onkogynekologa.php weekly 0.7 /artkey/xon-201705-0005_Serozni_tubarni_intraepitelialni_karcinomy_STIC.php weekly 0.7 /artkey/xon-201705-0006_paliativni_pece_v_gynekologicke_onkologii_8211_komentovane_kazuistiky.php weekly 0.7 /artkey/xon-201705-0007_Osetrovatelska_pece_o_operacni_ranu_po_radikalni_vulvektomii_per_secundam_8211_komentovana_kazuistikaz_pohle.php weekly 0.7 /artkey/xon-201705-0008_hladkosvalove_nadory_delozni_nejisteho_maligniho_potencialu.php weekly 0.7 /magno/xon/2017/mn6.php weekly 0.7 /artkey/xon-201706-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201706-0005_Osteosarkom.php weekly 0.7 /artkey/xon-201706-0006_Mnohocetny_myelom_a_diferencialni_diagnostika_bolesti_patere.php weekly 0.7 /artkey/xon-201706-0007_Multidisciplinarni_pristup_u_pacientu_s_neoverenym_tumorem_hrudniku.php weekly 0.7 /artkey/xon-201706-0008_Posuzovani_pracovni_schopnosti_a_socialni_aspekty_pece_u_onkologicky_nemocnych.php weekly 0.7 /artkey/xon-201706-0009_rekonstrukce_hypofaryngu_alt_volnym_lalokem_8211_kazuistika.php weekly 0.7 /artkey/xon-201706-0002_cytoredukcni_chirurgie_a_hypertermicka_intraperitonealni_chemoterapie_u_karcinomu_zaludku.php weekly 0.7 /artkey/xon-201706-0003_casne_a_pozdni_komplikace_cytoreduktivni_chirurgie_a_hypertermicke_intraperitonealni_chemoterapie.php weekly 0.7 /artkey/xon-201706-0004_vyznam_systemove_chemoterapie_a_hypertermicke_intraperitonealni_chemoterapie_u_primarnich_a_sekundarnich_malign.php weekly 0.7 /magno/xon/2016/mn1.php weekly 0.7 /artkey/xon-201601-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201601-0006_Nemalobunecne_karcinomy_plic-koncertantni_novinky_v_diagnostice_i_terapii.php weekly 0.7 /artkey/xon-201601-0010_Komplikace_lecby_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201601-0011_Bevacizumab_v_terapii_triple_negativniho_karcinomu_prsu.php weekly 0.7 /artkey/xon-201601-0013_Moderni_metody_imunoterapie_se_vyviji_i_v_Cesku.php weekly 0.7 /artkey/xon-201601-0002_Nova_WHO_klasifikace_nadoru_plic.php weekly 0.7 /artkey/xon-201601-0003_Molekularni_profilovani_nadoru_plic.php weekly 0.7 /artkey/xon-201601-0004_Doporucene_diagnosticke_a_lecebne_postupy_u_NSCLC_stadia_III.php weekly 0.7 /artkey/xon-201601-0005_Soucasny_stav_a_vyhlidky_cilene_lecby_nemalobunecneho_plicniho_karcinomu_NSCLC.php weekly 0.7 /artkey/xon-201601-0007_Soucasny_stav_a_vyhlidky_imunoterapie_NSCLC.php weekly 0.7 /artkey/xon-201601-0008_Pokracovaci_udrzovaci_lecba_pemetrexedemu_u_nemocnych_s_nemalobunecnym_karcinomem_plic_v_Ceske_repu.php weekly 0.7 /artkey/xon-201601-0012_Krevni_srazeniny_se_nevyplaci_podcenovat.php weekly 0.7 /artkey/xon-201601-0009_Brachyterapie_inoperabilniho_karcinomu_jicnu.php weekly 0.7 /magno/xon/2016/mn2.php weekly 0.7 /artkey/xon-201602-0001_Plati_Hippokratova_prisaha_i_v_roce_2016.php weekly 0.7 /artkey/xon-201602-0006_Lecba_pokrocileho_gastrointestinalniho_stromalniho_tumoru.php weekly 0.7 /artkey/xon-201602-0007_Rektovaginalni_pistel_jako_komplikace_chirurgicke_lecby_u_pacientek_s_karcinomem_rekta.php weekly 0.7 /artkey/xon-201602-0008_Neuromuskularni_symptomatologie_jako_prvni_769_projev_maligniho_onemocneni_a_puvodni_evolucni_vyz.php weekly 0.7 /artkey/xon-201602-0009_Psychicke_stavy_provazejici_navrat_do_zamestnani_po_onkologicke_nemoci.php weekly 0.7 /artkey/xon-201602-0010_Metastaticky_primarne_neresekabilni_karcinom_tlusteho_streva_manifestovany_v_gravidite_u_38lete_pac.php weekly 0.7 /artkey/xon-201602-0002_Bazaliom.php weekly 0.7 /artkey/xon-201602-0003_Primarni_kozni_lymfomy_soucasny_pohled_na_vzacna_hemato-onkologicka_onemocneni.php weekly 0.7 /artkey/xon-201602-0004_Kozni_paraneoplazie.php weekly 0.7 /artkey/xon-201602-0005_Axitinib_v_lecbe_metastatickeho_renalniho_karcinomu.php weekly 0.7 /magno/xon/2016/mn3.php weekly 0.7 /artkey/xon-201603-0001_Jak_se_divat_na_psychosomatiku.php weekly 0.7 /artkey/xon-201603-0006_Onkologicka_lecba_v_tehotenstvi.php weekly 0.7 /artkey/xon-201603-0007_Lecba_karcinomu_laryngu.php weekly 0.7 /artkey/xon-201603-0008_Zkusenosti_s_lecbou_pokrocileho_HER2_pozitivniho_karcinomu_prsu_ve_FN_Motol.php weekly 0.7 /artkey/xon-201603-0009_PET_CT_vysetreni_u_pacientu_s_karcinomem_prostaty.php weekly 0.7 /artkey/xon-201603-0010_Uspesny_mammarni_screening_v_Ceske_republice_bezi_jiz_patnacty_rok.php weekly 0.7 /artkey/xon-201603-0002_Myelodysplasticky_syndrom_v_roce_2016.php weekly 0.7 /artkey/xon-201603-0003_Soucasny_stav_lecby_chronicke_myeloidni_leukemie_pomoci_inhibitoru_tyrozinove_kinazy.php weekly 0.7 /artkey/xon-201603-0004_Smisene_myelodysplasticko-myeloproliferativni_syndromy.php weekly 0.7 /artkey/xon-201603-0005_Prognosticky_vyznam_survivinu_u_pacientu_s_lokalne_pokrocilym_adenokarcinomem_rekta_lecenych_pooper.php weekly 0.7 /magno/xon/2016/mn4.php weekly 0.7 /artkey/xon-201604-0001_Karcinom_prsu.php weekly 0.7 /artkey/xon-201604-0006_Karcinomy_stitne_zlazy_z_pohledu_onkologa-systemova_lecba.php weekly 0.7 /artkey/xon-201604-0007_Vyuziti_radioterapie_v_lecbe_adenokarcinomu_pankreatu.php weekly 0.7 /artkey/xon-201604-0009_Risk_adapted_terapie_u_I_klinickeho_stadia_neseminomu.php weekly 0.7 /artkey/xon-201604-0010_Supratentorialni_extraventrikularni_anaplasticke_ependymomy_WHO_stupne_III_Dve_kazuistiky.php weekly 0.7 /artkey/xon-201604-0002_Metronomicka_chemoterapie_u_karcinomu_prsu.php weekly 0.7 /artkey/xon-201604-0003_Lobularni_karcinom_prsu.php weekly 0.7 /artkey/xon-201604-0004_Karcinom_prsu_u_muzu.php weekly 0.7 /artkey/xon-201604-0005_Sporne_otazky_v_radioterapii_karcinomu_prsu.php weekly 0.7 /artkey/xon-201604-0008_Prognosticky_vyznam_hustoty_kapilar_urcovane_pomoci_protilatky_proti_CD34_a_CD105_u_pacientu_leceny.php weekly 0.7 /magno/xon/2016/mn5.php weekly 0.7 /artkey/xon-201605-0007_cilena_lecba_u_nadorovych_onemocneni_krve.php weekly 0.7 /artkey/xon-201605-0008_Kontrolovany_podtlak_pri_komplikovanem_hojeni_operacni_rany-kazuistika.php weekly 0.7 /artkey/xon-201605-0001_Histiocytozy_u_deti_a_dospivajicich.php weekly 0.7 /artkey/xon-201605-0002_Perinatalni_neuroblastom.php weekly 0.7 /artkey/xon-201605-0003_Retinoblastom.php weekly 0.7 /artkey/xon-201605-0004_Pediatricky_GIST.php weekly 0.7 /artkey/xon-201605-0005_Lecba_rabdomyosarkomu_detskeho_veku.php weekly 0.7 /artkey/xon-201605-0006_Prognosticky_vyznam_exprese_proteinu_p53_u_pacientu_lecenych_pooperacni_adjuvantni_radioterapii_pro.php weekly 0.7 /magno/xon/2016/mn6.php weekly 0.7 /artkey/xon-201606-0001_Kdo_bude_hlidat_hlidace.php weekly 0.7 /artkey/xon-201606-0002_Renalni_karcinom_a_imunoterapie.php weekly 0.7 /artkey/xon-201606-0003_Maligni_melanom_a_nove_moznosti_jeho_lecby.php weekly 0.7 /artkey/xon-201606-0004_imunoterapie_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201606-0005_systemova_lecba_karcinomu_mocoveho_mechyre.php weekly 0.7 /artkey/xon-201606-0006_Angiosarkom_prsu_po_aktinoterapii_po_zachovne_operaci_pro_karcinom.php weekly 0.7 /artkey/xon-201606-0007_zmena_barvy_kuze_jako_nezadouci_ucinek_pri_lecbe_sunitinibem_u_detske_pacientky_s_osteosarkomem.php weekly 0.7 /artkey/xon-201606-0008_Informovanost_chlapcu_ve_veku_15-19_let_o_prevenci_nadoroveho_onemocneni_varlat.php weekly 0.7 /magno/xon/2016/mn88.php weekly 0.7 /artkey/xon-201688-0001_jak_se_vyviji_lecba_karcinomu_plic.php weekly 0.7 /magno/xon/2015/mn1.php weekly 0.7 /artkey/xon-201501-0001_Idealy_a_oceneni_sester_v_roce_2015.php weekly 0.7 /artkey/xon-201501-0006_Patogeneze_kancerogenity_et_anolu_u_karcinomu_hlavy_a_krku.php weekly 0.7 /artkey/xon-201501-0007_Soucasna_indikace_systemove_neoadjuvantni_terapie_u_pacientek_s_karcinomem_prsu.php weekly 0.7 /artkey/xon-201501-0008_Supinacna_versus_pronacna_poloha_pri_adjuvantnej_radioterapii_u_pacientok_s_pendulujucimi_prsnikmi.php weekly 0.7 /artkey/xon-201501-0009_Neuroonkologicke_aspekty_u_nemocnych_s_farmakorezistentni_epilepsii.php weekly 0.7 /artkey/xon-201501-0010_Postaveni_cytogenetickeho_vysetreni_v_soucasnem_managementu_lecby_detske_akutni_lymfoblasticke_leuk.php weekly 0.7 /artkey/xon-201501-0011_Chyloperitoneum-zkusenost_naseho_pracoviste.php weekly 0.7 /artkey/xon-201501-0002_Renesance_imunoterapie_nadorovych_chorob.php weekly 0.7 /artkey/xon-201501-0003_Adoptivni_bunecna_terapie_pomoci_lymfocytu_T_v_lecbe_nadoru.php weekly 0.7 /artkey/xon-201501-0004_Imunoterapie_v_lecbe_solidnich_nadoru.php weekly 0.7 /artkey/xon-201501-0005_Imunoterapie_pomoci_CAR_T-lymfocytu.php weekly 0.7 /artkey/xon-201501-0012_Podpora_interkulturni_socialni_interakce_v_osetrovatelskem_vzdelavani_a_klinicke_praxi.php weekly 0.7 /magno/xon/2015/mn2.php weekly 0.7 /artkey/xon-201502-0002_Jahodove_blues.php weekly 0.7 /artkey/xon-201502-0007_Eribulin_mesylat_Halaven_174-nova_nadeje_pro_predlecene_pacientky_s_pokrocilym_a_metastatick.php weekly 0.7 /artkey/xon-201502-0008_Metastazy_jater_a_moznosti_intervencni_radiologie.php weekly 0.7 /artkey/xon-201502-0009_Prevence_a_lecba_infekci_u_nemocnych_se_solidnimi_nadory_lecenych_cilenou_lecbou.php weekly 0.7 /artkey/xon-201502-0010_Systemova_cilena_lecba_gastrointestinalnich_stromalnich_nadoru.php weekly 0.7 /artkey/xon-201502-0011_Postaveni_sublingvalniho_fentanylu_Lunaldin_174_v_klinicke_praxi_onkologa.php weekly 0.7 /artkey/xon-201502-0001_Karcinom_prsu-slovo_uvodem.php weekly 0.7 /artkey/xon-201502-0003_Moznosti_a_nasledne_souvislosti_vyplyvajici_z_genetickeho_testovani_pacientek_s_vysokym_rizikem_vzn.php weekly 0.7 /artkey/xon-201502-0004_Kontroverze_v_onkologicke_diagnostice_limity_a_vyhody_core_cut_biopsie_v_diagnostice_lezi_prsu.php weekly 0.7 /artkey/xon-201502-0005_Novy_pohled_na_opakovane_chirurgicke_vykony_u_karcinomu_prsu_se_zamerenim_na_pozitivitu_resekcnich.php weekly 0.7 /artkey/xon-201502-0006_Otazniky_v_neoadjuvantni_systemove_lecbe_karcinomu_prsu.php weekly 0.7 /artkey/xon-201502-0012_Vyznam_nemoci_dozivani_a_smrti_pro_soucasny_zivot_Romu_socialne-antropologicka_perspektiva.php weekly 0.7 /magno/xon/2015/mn3.php weekly 0.7 /artkey/xon-201503-0001_Komunikace_s_handicapovanymi.php weekly 0.7 /artkey/xon-201503-0007_Doporuceni_pro_cilenou_antimykotickou_terapii_invazivni_mykoticke_infekce_v_detske_hemato-onkologii.php weekly 0.7 /artkey/xon-201503-0008_Prvni_zkusenosti_s_vysetrenim_Oncotype_DX_u_pacientek_s_karcinomem_prsu.php weekly 0.7 /artkey/xon-201503-0009_Pouziti_epidemiologickych_dat_pri_odhadu_miry_rizika_vyskytu_zhoubnych_novotvaru_u_osob_exponovanyc.php weekly 0.7 /artkey/xon-201503-0010_Reevaluace_stagingu_nodalniho_statusu_nemalobunecneho_karcinomu_plic_NSCLC_leveho_horniho_laloku.php weekly 0.7 /artkey/xon-201503-0012_Lecba_nemocne_s_postizenim_centralniho_nervoveho_systemu_u_HER2_pozitivniho_karcinomu_prsu_v_kontex.php weekly 0.7 /artkey/xon-201503-0002_Leukemie-slovo_uvodem.php weekly 0.7 /artkey/xon-201503-0003_Chronicka_lymfocytarni_leukemie.php weekly 0.7 /artkey/xon-201503-0004_Myelodysplasticky_syndrom.php weekly 0.7 /artkey/xon-201503-0005_Chronicka_myeloidni_leukemie_v_roce_2015.php weekly 0.7 /artkey/xon-201503-0006_Akutni_lymfoblasticka_leukemie_dospelych.php weekly 0.7 /artkey/xon-201503-0011_Je_jeste_misto_pro_radioterapii_v_lecbe_nadoru_vajecniku.php weekly 0.7 /magno/xon/2015/mn4.php weekly 0.7 /artkey/xon-201504-0001_Kolorektalni_karcinom.php weekly 0.7 /artkey/xon-201504-0007_Imunoterapie_metastazujiciho_melanomu.php weekly 0.7 /artkey/xon-201504-0008_Lecba_nemalobunecneho_plicniho_karcinomu_Giotrifem_174_afatinibem.php weekly 0.7 /artkey/xon-201504-0009_Zhoubne_nadory_a_gravidita.php weekly 0.7 /artkey/xon-201504-0010_Adjuvantni_chemoterapie_u_vysoce_rizikoveho_karcinomu_endometria.php weekly 0.7 /artkey/xon-201504-0011_Pripad_domnele_pneumotoxicity_topotekanu.php weekly 0.7 /artkey/xon-201504-0002_Screening_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201504-0003_Vyznam_testovani_RAS_u_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201504-0004_Strategie_chirurgicke_lecby_synchronnich_jaternich_metastaz_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201504-0005_Protonova_radioterapie_u_nadoru_kolorekta-moznosti_a_ocekavani.php weekly 0.7 /artkey/xon-201504-0006_Kolorektalni_karcinom-soucasny_pohled_na_rizikove_a_protektivni_faktory_moznosti_prevence.php weekly 0.7 /magno/xon/2015/mn5.php weekly 0.7 /artkey/xon-201505-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201505-0006_Karcinoid_plic-pokroky_v_molekularni_biologii_a_jejich_prakticke_vyuziti.php weekly 0.7 /artkey/xon-201505-0007_Recidivy_gynekologickych_malignit.php weekly 0.7 /artkey/xon-201505-0008_Lecba_bolesti_u_onkologickych_pacientu_se_zamerenim_na_prulomovou_bolest.php weekly 0.7 /artkey/xon-201505-0009_Kolorektalni_karcinom_v_detskem_veku.php weekly 0.7 /artkey/xon-201505-0011_Lecba_chronicke_a_prulomove_bolesti_u_nadoroveho_onemocneni_slinivky.php weekly 0.7 /artkey/xon-201505-0012_ESMO_2015_Co_noveho_v_lecbe_mCRC.php weekly 0.7 /artkey/xon-201505-0002_Komplexni_terapie_gliomu_mozku.php weekly 0.7 /artkey/xon-201505-0003_Komplexni_lecba_adenomu_hypofyzy.php weekly 0.7 /artkey/xon-201505-0004_Komplexni_lecba_meningeomu_mozku.php weekly 0.7 /artkey/xon-201505-0005_Zobrazovaci_metody_a_elektrofyziologie_pri_chirurgicke_lecbe_nadoru_mozku.php weekly 0.7 /artkey/xon-201505-0010_Metoda_RNAscope_174_pro_analyzu_exprese_HER2_ve_vzorcich_karcinomu_mlecne_zlazy_s_neprokazanou_am.php weekly 0.7 /magno/xon/2015/mn6.php weekly 0.7 /artkey/xon-201506-0001_Pozitivni_emoce_a_zdravi.php weekly 0.7 /artkey/xon-201506-0006_Aktualni_moznosti_chemoradioterapie_lokalne_pokrocileho_karcinomu_rekta.php weekly 0.7 /artkey/xon-201506-0007_kontroverze_v_hormonalni_lecbe_kastracne_refrakterniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201506-0008_Zilni_pristupy_pro_strednedobou_a_dlouhodobou_protinadorovou_lecbu.php weekly 0.7 /artkey/xon-201506-0009_Manazment_diagnostiky_a_liecby_chronickej_myelomonocytovej_leukemie-pohlad_z_klinickej_praxe.php weekly 0.7 /artkey/xon-201506-0002_Pokrocily_karcinom_pankreatu.php weekly 0.7 /artkey/xon-201506-0003_Karcinom_anu.php weekly 0.7 /artkey/xon-201506-0004_Karcinom_zaludku.php weekly 0.7 /artkey/xon-201506-0005_Nove_leky_v_lecbe_karcinomu_zaludku.php weekly 0.7 /magno/xon/2015/mn88.php weekly 0.7 /artkey/xon-201588-0001_Proceedings_from_the_7th_International_Conference_of_Hospice_and_Palliative_Care.php weekly 0.7 /magno/xon/2014/mn1.php weekly 0.7 /artkey/xon-201401-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201401-0007_Nove_moznosti_v_lecbe_myelodysplastickeho_syndromu.php weekly 0.7 /artkey/xon-201401-0008_Torakoskopicky_navozena_chemicka_pleurodeza_v_lecbe_maligniho_pleuralniho_vypotku.php weekly 0.7 /artkey/xon-201401-0009_Lecba_chemoterapii_indukovane_polyneuropatie_u_nemocne_s_metastatickym_kolorektalnim_karcinomem.php weekly 0.7 /artkey/xon-201401-0010_Bevacizumab_v_terapii_metastatickeho_karcinomu_prsu.php weekly 0.7 /artkey/xon-201401-0002_Imunoterapie_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201401-0003_Uloha_radikalni_prostatektomie_v_lecbe_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201401-0004_Diagnostika_a_staging_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201401-0005_Radioterapie_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201401-0011_Zvladani_bolesti_u_onkologickych_pacientu_v_osetrovatelske_peci.php weekly 0.7 /artkey/xon-201401-0006_Radium-223_dichlorid_Xofigo-v_managementu_lecby_metastatickeho_kastracne_rezistentniho_karcinom.php weekly 0.7 /magno/xon/2014/mn2.php weekly 0.7 /artkey/xon-201402-0001_Nektere_uzitecne_prvky_komunikace.php weekly 0.7 /artkey/xon-201402-0006_Novinky_v_diagnostice_prediktivnich_markeru_u_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201402-0007_Hormonalni_lecba_kastracne_refrakterniho_karcinomu_prostaty_CRPC_existuji_linie_lecby.php weekly 0.7 /artkey/xon-201402-0008_Cilena_lecba_metastatickeho_renalniho_karcinomu_moznosti_sekvencni_lecby_soucasny_pohled.php weekly 0.7 /artkey/xon-201402-0009_Moderni_trendy_v_lecbe_pokrocileho_maligniho_melanomu.php weekly 0.7 /artkey/xon-201402-0002_Gynekologicke_nadory_u_dospivajicich_a_mladych_zen-uvod_do_problematiky.php weekly 0.7 /artkey/xon-201402-0003_Nadory_ovarii_u_deti_a_adolescentnich_divek.php weekly 0.7 /artkey/xon-201402-0004_Reprodukcni_ochrana_u_dospivajicich_divek_s_malignim_onemocnenim.php weekly 0.7 /artkey/xon-201402-0005_Dalsi_novotvary_u_prezivajicich_do_49_let_s_gynekologickymi_nadory.php weekly 0.7 /artkey/xon-201402-0010_Komplikace_lecby_karcinomu_delozniho_hrdla.php weekly 0.7 /magno/xon/2014/mn3.php weekly 0.7 /artkey/xon-201403-0001_Nestihnout_vyhoret.php weekly 0.7 /artkey/xon-201403-0007_Alogenni_transplantace_kmenovych_bunek_v_lecbe_malignich_onemocneni_krvetvorby_u_deti.php weekly 0.7 /artkey/xon-201403-0008_Kostni_sarkomy_a_postaveni_systemove_lecby_v_jejich_lecebnem_algoritmu.php weekly 0.7 /artkey/xon-201403-0009_Koncept_preruseni_biologicke_lecby_tyrozinkinazovymi_inhibitory_u_chronicke_myeloidni_leukemie.php weekly 0.7 /artkey/xon-201403-0010_Extramedularny_relaps_akutnej_leukemie_v_prsnych_zlazach_po_alogennej_transplantacii_krvotvornych_k.php weekly 0.7 /artkey/xon-201403-0011_Toxicita_lecby_docetaxelem_u_pacientek_s_karcinomem_prsu.php weekly 0.7 /artkey/xon-201403-0012_Brnenske_sympozium_o_intravenoznim_podavani_vysokodavkovaneho_vitaminu_C_onkologickym_pacientum.php weekly 0.7 /artkey/xon-201403-0002_Hodgkinuv_lymfom-slovo_uvodem.php weekly 0.7 /artkey/xon-201403-0003_Moznosti_diagnostiky_CD5-pozitivnich_B-lymfoproliferaci.php weekly 0.7 /artkey/xon-201403-0004_Prinos_casneho_PET_CT_vysetreni_pro_prognostickou_stratifikaci_a_lecbu_nemocnych_s_difuznim_B-velko.php weekly 0.7 /artkey/xon-201403-0005_Lecba_lokalizovaneho_stadia_Hodgkinova_lymfomu.php weekly 0.7 /artkey/xon-201403-0006_Soucasne_pohledy_na_lecbu_nemocnych_v_pokrocilem_stadiu_Hodgkinova_lymfomu.php weekly 0.7 /magno/xon/2014/mn4.php weekly 0.7 /artkey/xon-201404-0001_Zvladani_stresu_v_lekarskych_profesich.php weekly 0.7 /artkey/xon-201404-0005_Kolorektalni_karcinom_u_senioru.php weekly 0.7 /artkey/xon-201404-0006_Invazivni_mykoticke_infekce.php weekly 0.7 /artkey/xon-201404-0007_Vyuziti_DIEP_laloku_k_rekonstrukci_prsu_po_ablaci_pro_cystosarcoma_phyllodes.php weekly 0.7 /artkey/xon-201404-0008_Orofacialni_metastazy_organovych_malignit.php weekly 0.7 /artkey/xon-201404-0010_Co_noveho_v_lecbe_metastatickeho_kolorektalniho_karcinomu_po_cervnovem_Congress_on_Gastrointestinal.php weekly 0.7 /artkey/xon-201404-0011_ASCO_2014.php weekly 0.7 /artkey/xon-201404-0002_Sledovani_nemocnych_s_plicnim_karcinoidem_2002-2013.php weekly 0.7 /artkey/xon-201404-0003_Vyskyt_mutaci_genu_EGFR_u_pacientu_s_NSCLC_v_Ceske_republice.php weekly 0.7 /artkey/xon-201404-0004_Imunoterapie_u_karcinomu_plic.php weekly 0.7 /artkey/xon-201404-0009_Medikacni_pochybeni_z_perspektivy_managementu_zdravotnickeho_zarizeni.php weekly 0.7 /magno/xon/2014/mn5.php weekly 0.7 /artkey/xon-201405-0001_Vzdelavani_lekaru-vcera-dnes-zitra.php weekly 0.7 /artkey/xon-201405-0006_Vyznam_spoluprace_urologa_a_onkologa_v_lecbe_kastracne_rezistentniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201405-0007_Prediktivni_biomarker_RAS_krizovatka_nebo_pokracovani_v_nastolene_ceste-letni_update_roku_2014.php weekly 0.7 /artkey/xon-201405-0008_Lecba_pacientek_s_karcinomem_prsu_tamoxifenem_a_jeho_vliv_na_endometrium_z_pohledu_gynekologa.php weekly 0.7 /artkey/xon-201405-0009_Hormonalni_lecba_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201405-0010_Cilena_lecba_versus_klasicka_cytostatika.php weekly 0.7 /artkey/xon-201405-0011_Pacient_s_metastatickym_karcinomem_ledviny_a_idiopatickou_trombocytopenickou_purpurou_leceny_suniti.php weekly 0.7 /artkey/xon-201405-0012_Metastaticky_karcinom_ledviny-2_linie_lecby.php weekly 0.7 /artkey/xon-201405-0002_Nadory_ledvin.php weekly 0.7 /artkey/xon-201405-0003_Karcinom_ledviny_z_pohledu_onkologa.php weekly 0.7 /artkey/xon-201405-0004_Karcinom_ledviny_z_pohledu_urologa.php weekly 0.7 /artkey/xon-201405-0005_Radioterapie_renalniho_karcinomu.php weekly 0.7 /magno/xon/2014/mn6.php weekly 0.7 /artkey/xon-201406-0001_Galerie_pro_onkologicke_pacienty.php weekly 0.7 /artkey/xon-201406-0006_Kardiovaskularni_nezadouci_ucinky_protinadorovych_leciv.php weekly 0.7 /artkey/xon-201406-0007_Prehled_diagnostiky_a_lecby_karcinomu_delozniho_hrdla.php weekly 0.7 /artkey/xon-201406-0008_Moznosti_nutricni_intervence_pri_onkologicke_lecbe.php weekly 0.7 /artkey/xon-201406-0009_Dalsi_novotvary_u_prezivajicich_s_bronchogennim_karcinomem_v_CR.php weekly 0.7 /artkey/xon-201406-0010_Rozsahly_spinalni_schwannom_v_lumbalni_urovni.php weekly 0.7 /artkey/xon-201406-0011_Paty_svetovy_kongres_Mezinarodni_federace_onkologie_hlavy_a_krku.php weekly 0.7 /artkey/xon-201406-0012_Karcinom_slinivky_brisni_je_stale_opomijena_hrozba_mezi_solidnimi_nadory.php weekly 0.7 /artkey/xon-201406-0002_Gastrointestinalni_stromalni_nadory-slovo_uvodem.php weekly 0.7 /artkey/xon-201406-0003_Diagnostika_gastrointestinalnich_stromalnich_tumoru.php weekly 0.7 /artkey/xon-201406-0004_Molekularni_genetika_u_gastrointestinalnich_stromalnich_tumoru.php weekly 0.7 /artkey/xon-201406-0005_Gastrointestinalni_stromalni_tumory_morfologicka_a_imunohistochemicka_vysetreni_z_pohledu_bioptick.php weekly 0.7 /magno/xon/2013/mn1.php weekly 0.7 /artkey/xon-201301-0001_Prediktivni_preventivni_personalifi_kovana_medicina-prislib_do_budoucnosti.php weekly 0.7 /artkey/xon-201301-0007_Moderni_individualizovana_lecba_chronicke_lymfocytarni_leukemie.php weekly 0.7 /artkey/xon-201301-0008_Imunoterapie_karcinomu_mocoveho_mechyre.php weekly 0.7 /artkey/xon-201301-0009_Lecba_chronicke_lymfocytarni_leukemie_u_nemocnych_vyssiho_veku_a_s_vyznamnymi_pridruzenymi_onemocne.php weekly 0.7 /artkey/xon-201301-0010_Nadory_zdravi_a_ekonomika-soucast_Pandoriny_skrinky.php weekly 0.7 /artkey/xon-201301-0011_Leky_prirodniho_puvodu_a_jejich_potencialni_protinadorovy_ucinek.php weekly 0.7 /artkey/xon-201301-0012_Vyuziti_cetuximabu_v_1_linii_konverzni_lecby_metastatickeho_kolorektalniho_karcinomu_do_jater.php weekly 0.7 /artkey/xon-201301-0013_Prinos_versus_toxicita_temozolomidu_u_pacientu_s_glioblastomem.php weekly 0.7 /artkey/xon-201301-0002_Uvodem_do_problematiky_bisfosfonatu.php weekly 0.7 /artkey/xon-201301-0003_Protinadorova_aktivita_bisfosfonatu.php weekly 0.7 /artkey/xon-201301-0004_Bisfosfonaty_v_lecbe_kostniho_postizeni_u_myelomu.php weekly 0.7 /artkey/xon-201301-0005_Bisfosfonaty_u_urologickych_malignit.php weekly 0.7 /artkey/xon-201301-0006_Postaveni_denosumabu_v_lecbe_kostnich_metastaz.php weekly 0.7 /magno/xon/2013/mn2.php weekly 0.7 /artkey/xon-201302-0001_Naucme_se_jednat_s_detmi_lecenymi_pro_zhoubny_nador_jako_s_ostatnimi_Vyhneme_se_prehnanemu_soucitu.php weekly 0.7 /artkey/xon-201302-0007_Nechirurgicka_lecba_metastazujiciho_karcinomu_ledviny.php weekly 0.7 /artkey/xon-201302-0008_Erlotinib_v_lecbe_pokrocileho_karcinomu_pankreatu.php weekly 0.7 /artkey/xon-201302-0009_Kvalita_zivota_pacienta_leceneho_cabazitaxelem_pro_metastaticky_karcinom_prostaty.php weekly 0.7 /artkey/xon-201302-0010_Koincidence_karcinomu_ledviny_a_Gaucherovy_choroby.php weekly 0.7 /artkey/xon-201302-0011_Cetuximab_podavany_konkomitantne_s_radioterapii_u_pacienta_s_lokalne_pokrocilym_p_16_negativnim_kar.php weekly 0.7 /artkey/xon-201302-0013_Prague_ONCO_2013-videno_z_publika.php weekly 0.7 /artkey/xon-201302-0014_Prague_Onco_2013-vyznamny_host.php weekly 0.7 /artkey/xon-201302-0002_Maligni_melanom-slovo_uvodem.php weekly 0.7 /artkey/xon-201302-0003_Soucasne_moznosti_lecby_pokrocileho_a_metastatickeho_maligniho_melanomu.php weekly 0.7 /artkey/xon-201302-0004_Maligni_melanom_u_deti_a_adolescentu.php weekly 0.7 /artkey/xon-201302-0005_Vyuziti_fluorescencni_in_situ_hybridizace_v_diagnostice_melanocytarnich_lezi.php weekly 0.7 /artkey/xon-201302-0006_Histologicke_zmeny_maligniho_melanomu_oka_po_provedene_radioterapii_CyberKnifem.php weekly 0.7 /artkey/xon-201302-0012_lecba_u_karcinomu_zaludku_Komentar_k_clanku_Krishna_S_Gunthuru_Yanghee_Woo_a_kol_8222_Gastric.php weekly 0.7 /magno/xon/2013/mn3.php weekly 0.7 /artkey/xon-201303-0001_Potrebuji_lekari_lekarskou_etiku.php weekly 0.7 /artkey/xon-201303-0009_Cilena_lecba_metastatickeho_melanomu_vemurafenibem.php weekly 0.7 /artkey/xon-201303-0010_Lecebne_moznosti_u_multicentricke_Castlemanovy_choroby.php weekly 0.7 /artkey/xon-201303-0011_Vysledky_lecby_a_sledovani_pacientu_se_spinocelularnimi_karcinomy_hlavy_a_krku_po_konkomitantni_lec.php weekly 0.7 /artkey/xon-201303-0002_Lymfoidni_malignity_se_zamerenim_na_vzacnejsi_nehodgkinovy_lymfomy-_uvodni_slovo.php weekly 0.7 /artkey/xon-201303-0003_Novinky_v_lecbe_akutni_lymfoblasticke_leukemie_dospelych.php weekly 0.7 /artkey/xon-201303-0004_Chronicka_lymfocytarni_leukemie-diagnostika_a_lecba.php weekly 0.7 /artkey/xon-201303-0005_Nove_perspektivy_v_patogenezi_a_diagnostice_lymfomu_z_plastovych_bunek_mantle_cell_lymfomu.php weekly 0.7 /artkey/xon-201303-0006_Primarni_lymfom_centralni_nervove_soustavy.php weekly 0.7 /artkey/xon-201303-0007_CNS_progrese_u_agresivnich_lymfomu_incidence_rizikove_faktory_profylakticke_a_lecebne_moznosti.php weekly 0.7 /artkey/xon-201303-0013_Reverzni_izolace-chrani_nebo_zatezuje_pacienty_po_transplantaci_kostni_drene.php weekly 0.7 /artkey/xon-201303-0012_Nejmodernejsi_anti-EGFR_cilena_lecba_u_metastazujiciho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201303-0008_Vyskyt_dalsich_novotvaru_u_nemocnych_s_leukemii.php weekly 0.7 /magno/xon/2013/mn4.php weekly 0.7 /artkey/xon-201304-0001_Je_potrebna_znalost_multikulturni_zdravotni_pece.php weekly 0.7 /artkey/xon-201304-0009_Vyuziti_intravenozniho_vitaminu_C_u_onkologickeho_pacienta.php weekly 0.7 /artkey/xon-201304-0010_Lecba_metastazujiciho_karcinomu_ledviny_ve_druhe_a_dalsich_liniich.php weekly 0.7 /artkey/xon-201304-0011_Kazuistika_pacienta_s_karcinomem_rekta_u_ktereho_doslo_ke_kompletni_klinicke_odpovedi_jaterniho_po.php weekly 0.7 /artkey/xon-201304-0002_Idiopaticke_strevni_zanety_a_kolorektalni_karcinom.php weekly 0.7 /artkey/xon-201304-0003_Klasifikace_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201304-0004_Screening_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201304-0005_Chirurgicka_lecba_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201304-0006_Endoskopicka_lecba_casnych_kolorektalnich_neoplazii.php weekly 0.7 /artkey/xon-201304-0007_Systemova_protinadorova_lecba_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201304-0008_Nemocni_s_karcinomem_kolorekta_a_jejich_nasledne_a_predchazejici_novotvary.php weekly 0.7 /magno/xon/2013/mn5.php weekly 0.7 /artkey/xon-201305-0001_Paliativni_pece_napric_radiacni_a_klinickou_onkologii.php weekly 0.7 /artkey/xon-201305-0006_Nove_moznosti_jaterni_chirurgie_u_primarne_neoperabilnich_nadoru_jater.php weekly 0.7 /artkey/xon-201305-0007_Pokrocily_karcinom_prostaty_a_nove_leky_z_pohledu_onkologa.php weekly 0.7 /artkey/xon-201305-0008_Podpurna_lecba_v_onkologii_stimulace_bile_krevni_rady.php weekly 0.7 /artkey/xon-201305-0009_Chemoterapia_pokrocileho_karcinomu_zaludka-potrebujeme_novy_liek.php weekly 0.7 /artkey/xon-201305-0010_Novy_prediktivni_biomarker_RAS_krizovatka_nebo_pokracovani_v_nastolene_ceste.php weekly 0.7 /artkey/xon-201305-0011_Vyuziti_biologicke_aktivity_quercetinu_v_lecbe_onkologickych_onemocneni.php weekly 0.7 /artkey/xon-201305-0012_Adenom_pristitneho_teliska.php weekly 0.7 /artkey/xon-201305-0013_Pacientka_s_uplnou_odpovedi_jaternich_a_kostnich_metastaz_pri_lecbe_paclitaxelem_bevacizumabem.php weekly 0.7 /artkey/xon-201305-0014_Vyznam_prukazu_RAS_mutaci_pro_anti-EGFR_protilatky_v_lecbe_1_linie_metastazujiciho_kolorektalniho.php weekly 0.7 /artkey/xon-201305-0002_Karcinom_prsu-slovo_uvodem.php weekly 0.7 /artkey/xon-201305-0003_Karcinom_prsu_u_starsich_zen.php weekly 0.7 /artkey/xon-201305-0004_Geneticky_podmineny_karcinom_prsu.php weekly 0.7 /artkey/xon-201305-0005_Nove_postupy_v_adjuvantni_radioterapii_karcinomu_prsu.php weekly 0.7 /artkey/xon-201305-0015_Potreby_rodicu_onkologicky_nemocnych_deti_ocima_rodicu_a_sester.php weekly 0.7 /magno/xon/2013/mn6.php weekly 0.7 /artkey/xon-201306-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201306-0004_Neoadjuvantni_lecba_karcinomu_rekta.php weekly 0.7 /artkey/xon-201306-0005_Angiosarkom_dolni_celisti.php weekly 0.7 /artkey/xon-201306-0006_Multidisciplinarni_pristup_v_lecbe_metastatickeho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201306-0008_2013_International_Multinational_Association_of_Supportive_Care_in_Cancer_International_Society_for.php weekly 0.7 /artkey/xon-201306-0009_Diky_presnejsi_selekci_pacientu_s_mCRC_s_vyloucenim_mutaci_vice_genu_RAS_muze_cetuximab_jeste_vyzna.php weekly 0.7 /artkey/xon-201306-0010_Kognitivne-behavioralni_terapie_u_umirajicich_onkologickych_pacientu.php weekly 0.7 /artkey/xon-201306-0011_Hodnotici_nastroje_pro_zjistovani_potreb_pacientu_v_paliativni_peci.php weekly 0.7 /artkey/xon-201306-0007_Regorafenib_v_monoterapii_u_predleceneho_metastatickeho_kolorektalniho_karcinomu_CORRECT_mezinar.php weekly 0.7 /artkey/xon-201306-0002_Nadorova_tkanova_banka_jako_zdroj_novych_dulezitych_informaci_k_prediktivnim_a_prognostickym_faktor.php weekly 0.7 /artkey/xon-201306-0003_Stereotakticka_radioterapie_a_radiochirurgie_primarnich_tumoru_mozku.php weekly 0.7 /magno/xon/2012/mn1.php weekly 0.7 /artkey/xon-201201-0001_Jak_je_to_s_personalizovanou_medicinou.php weekly 0.7 /artkey/xon-201201-0007_Cilena_lecba_u_pokrocileho_karcinomu_zaludku-novinky_v_lecbe_karcinomu_zaludku.php weekly 0.7 /artkey/xon-201201-0008_Neoadjuvantni_terapie_karcinomu_slinivky_brisni.php weekly 0.7 /artkey/xon-201201-0009_Pozdni_vedlejsi_ucinky_onkologicke_lecby_u_dlouhodobe_prezivajicich_pacientu.php weekly 0.7 /artkey/xon-201201-0010_Neoadjuvantni_chemoterapie_u_pacientky_s_nizkou_proliferaci.php weekly 0.7 /artkey/xon-201201-0011_Polekovy_halucinatorni_syndrom_u_pacientky_s_karcinomem_prsu.php weekly 0.7 /artkey/xon-201201-0012_Seminar_CECOG_o_cilene_a_individualizovane_lecbe_metastazujiciho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201201-0002_Lecba_nadorove_bolesti_v_roce_2012-multimodalni_pristup_a_pragmaticka_polypragmazie.php weekly 0.7 /artkey/xon-201201-0003_Kostni_nadorova_bolest_a_moznosti_jeji_lecby.php weekly 0.7 /artkey/xon-201201-0004_Neuropaticka_bolest_u_onkologickeho_pacienta.php weekly 0.7 /artkey/xon-201201-0005_Visceralni_bolest_v_onkologii.php weekly 0.7 /artkey/xon-201201-0006_Psychologicke_a_spiritualni_aspekty_nadorove_bolesti.php weekly 0.7 /artkey/xon-201201-0013_Boehringer_Ingelheim_spousti_program_klinickych_studii_faze_III_s_afatinibem_u_pacientu_s_karcinom.php weekly 0.7 /magno/xon/2012/mn2.php weekly 0.7 /artkey/xon-201202-0001_Perspektivy_a_moznosti_lekarske_techniky.php weekly 0.7 /artkey/xon-201202-0008_Nove_moznosti_nakladne_pneumoonkologicke_lecby_pokrocileho_nemalobunecneho_karcinomu_plic_NSCLC_v.php weekly 0.7 /artkey/xon-201202-0009_Metformin-nova_hvezda_onkologicke_lecby.php weekly 0.7 /artkey/xon-201202-0010_Vybrane_akutni_stavy_u_nemocnych_zarazenych_do_programu_paliativni_onkologicke_pece.php weekly 0.7 /artkey/xon-201202-0011_Lecba_Ewingova_sarkomu_periferniho_neuroektodermalniho_tumoru_dospelych.php weekly 0.7 /artkey/xon-201202-0012_First-Line_XELOX_Plus_Bevacizumab_Followed_by_XELOX_Plus_Bevacizumab_or_Single-Agent_Bevacizumab_as.php weekly 0.7 /artkey/xon-201202-0013_Kazuistika_nemocne_s_bronchogennim_neuroendokrinnim_nadorem.php weekly 0.7 /artkey/xon-201202-0014_Kazuistika_kompletni_odpovedi_ORL_tumoru_na_konkomitantni_lecbu_radioterapii_s_cetuximabem.php weekly 0.7 /artkey/xon-201202-0015_Lecba_bronchogenniho_karcinomu_gefitinibem_v_I_linii_u_pacienta_s_pozitivni_mutaci_EGFR.php weekly 0.7 /artkey/xon-201202-0016_Novinky_v_diagnostice_a_lecbe_primarnich_nadoru_mozku-zavery_mezioboroveho_setkani_8222_Winter.php weekly 0.7 /artkey/xon-201202-0002_Karcinom_ovaria-slovo_uvodem.php weekly 0.7 /artkey/xon-201202-0003_Predoperacni_diagnostika_ovarialnich_nadoru.php weekly 0.7 /artkey/xon-201202-0004_CA125_MUC16_jako_diagnosticky_a_prognosticky_marker_pro_karcinom_ovaria.php weekly 0.7 /artkey/xon-201202-0005_Antiangiogenni_lecba_ovarialniho_karcinomu.php weekly 0.7 /artkey/xon-201202-0006_Primarni_chirurgicka_lecba_karcinomu_ovaria.php weekly 0.7 /artkey/xon-201202-0007_Epidemiologie_nadoru_delozniho_hrdla_delozniho_tela_a_vajecniku_u_svetove_populace.php weekly 0.7 /magno/xon/2012/mn3.php weekly 0.7 /artkey/xon-201203-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201203-0008_Kolonicka_kapsle_v_kontextu_screeningu_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201203-0009_Hormon_refrakterni_karcinom_a_medikamentozni_lecba.php weekly 0.7 /artkey/xon-201203-0010_Vyznam_nutricni_pece_u_onkologickeho_pacienta_Vyvoj_nutricni_pece_v_Ustavu_radiacni_onkologie.php weekly 0.7 /artkey/xon-201203-0011_Mame_se_k_HPV_pozitivnim_karcinomum_orofaryngu_chovat_jinak.php weekly 0.7 /artkey/xon-201203-0002_Comments_on_WHO_Classification_of_Ph-Negative_Myeloproliferative_Neoplasms_MPN_and_Overview_of_th.php weekly 0.7 /artkey/xon-201203-0003_Biopsia_kostnej_drene_pri_myeloproliferativnych_neoplaziach-potreba_ci_prezitok.php weekly 0.7 /artkey/xon-201203-0004_Stem_Cell_Involvement_in_Myeloproliferative_Neoplasms.php weekly 0.7 /artkey/xon-201203-0005_Molecular_Genetics_in_Diagnosis_and_Prognosis_of_Philadelphia_Chromosome_Negative_Myeloproliferativ.php weekly 0.7 /artkey/xon-201203-0006_Cytogenetika_a_molekularni_cytogenetika_v_diagnostice_a_stanoveni_prognozy_myeloproliferativnich_ne.php weekly 0.7 /artkey/xon-201203-0007_Comments_on_ELN_Recommendations_to_Diagnosis_Prognosis_and_Treatment_of_Polycythemia_Vera_and_Esse.php weekly 0.7 /artkey/xon-201203-0012_Afatinib_vykazuje_v_registracni_studii_bezprecedentni_ucinnost_v_prvni_linii_lecby_u_pacientu_s_pl.php weekly 0.7 /magno/xon/2012/mn4.php weekly 0.7 /artkey/xon-201204-0001_Realne_dopady_starnuti_populace.php weekly 0.7 /artkey/xon-201204-0007_Biologicka_liecba_chronickej_myelocytovej_leukemie.php weekly 0.7 /artkey/xon-201204-0008_Farmakokinetika_ucinek_a_tolerabilita_5-fluorouracilu_behem_predoperacni_chemoradioterapie_lokalne.php weekly 0.7 /artkey/xon-201204-0010_Prinos_stereotakticke_biopsie_pro_diagnostiku_expanzi_zadni_jamy_lebni.php weekly 0.7 /artkey/xon-201204-0011_Kazuistika_karcinomu_oropharyngu_s_pouzitim_kombinovane_lecby_cetuximab_s_radioterapii_u_59leteho_p.php weekly 0.7 /artkey/xon-201204-0002_Nadory_skeletu-slovo_uvodem.php weekly 0.7 /artkey/xon-201204-0003_Nektere_aspekty_ortopedicke_onkologie.php weekly 0.7 /artkey/xon-201204-0004_P_rimarni_maligni_kostni_nadory_z_pohledu_histopatologa.php weekly 0.7 /artkey/xon-201204-0005_Soucasne_ortopedicke_postupy_v_lecbe_kostnich_sarkomu.php weekly 0.7 /artkey/xon-201204-0006_Pokroky_ve_farmakoterapii_kostnich_sarkomu.php weekly 0.7 /artkey/xon-201204-0009_Retreatment_trastuzumabem_po_progresi_na_lecbe_trastuzumabem_a_lapatinibem_u_pacientek_s_metastatic.php weekly 0.7 /magno/xon/2012/mn5.php weekly 0.7 /artkey/xon-201205-0001_Prava_a_povinnosti_lekaru.php weekly 0.7 /artkey/xon-201205-0008_Prime_naklady_adjuvantni_cytostaticke_lecby_kolorektalniho_karcinomu_III_stadia-rozdil_v_peroral.php weekly 0.7 /artkey/xon-201205-0009_Neoadjuvantni_chemoterapie_u_jaternich_metastaz_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201205-0010_Neoadjuvantna_liecba_karcinomov_prsnika.php weekly 0.7 /artkey/xon-201205-0011_Lecba_kozni_toxicity_u_nemocne_s_metastazujicim_kolorektalnim_karcinomem_lecene_cetuximabem-klini.php weekly 0.7 /artkey/xon-201205-0012_Sunitinib_u_neuroendokrinniho_nadoru.php weekly 0.7 /artkey/xon-201205-0013_Lecba_nemalobunecneho_plicniho_karcinomu_gefitinibem.php weekly 0.7 /artkey/xon-201205-0002_Nadory_hlavy_a_krku-slovo_uvodem.php weekly 0.7 /artkey/xon-201205-0003_Nadorove_markery_u_dlazdicovych_karcinomu_hlavy_a_krku.php weekly 0.7 /artkey/xon-201205-0004_Moderni_technologie_v_radioterapii_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-201205-0005_Brachyterapie_nadoru_ORL_oblasti.php weekly 0.7 /artkey/xon-201205-0006_Soucasna_uloha_chemoterapie_a_cilene_biologicke_lecby_v_kurativni_a_paliativni_lecbe_spinocelularni.php weekly 0.7 /artkey/xon-201205-0007_Nemocni_s_vicecetnymi_nadory_hlavy_a_krku.php weekly 0.7 /artkey/xon-201205-0014_Vetsina_onkologickych_pacientu_je_naklonena_zpozdeni_lecby_vymenou_za_benefit_ktery_jim_personaliz.php weekly 0.7 /artkey/xon-201205-0015_Vysledky_pripravku_Erbitux_174_u_pacientu_s_rakovinou_hlavy_a_krku_se_zdaji_byt_nezavisle_na_stav.php weekly 0.7 /magno/xon/2012/mn6.php weekly 0.7 /artkey/xon-201206-0001_Komunikace_na_onkologickych_pracovistich.php weekly 0.7 /artkey/xon-201206-0005_Neuroendokrinni_nadory_zaludku.php weekly 0.7 /artkey/xon-201206-0006_Systemova_terapie_mozkovych_metastaz.php weekly 0.7 /artkey/xon-201206-0007_Moznosti_zobrazovani_lymfatickych_uzlin.php weekly 0.7 /artkey/xon-201206-0008_Detekce_multifokalniho_karcinomu_prsu_pomoci_18F-FDG_PET_CT_u_pacientky_s_negativni_mamografii_bio.php weekly 0.7 /artkey/xon-201206-0009_Panitumumab_v_lecbe_nemocnych_s_pokrocilym_metastazujicim_kolorektalnim_karcinomem.php weekly 0.7 /artkey/xon-201206-0010_Pokrocily_karcinom_jicnu_Multidisciplinarni_lecba-vlastni_zkusenosti.php weekly 0.7 /artkey/xon-201206-0011_Lecba_metastazujiciho_kolorektalniho_karcinomu_2_narodni_multidisciplinarni_workshop.php weekly 0.7 /artkey/xon-201206-0012_Chemodektom-charakteristika_zkusenosti_s_lecbou.php weekly 0.7 /artkey/xon-201206-0013_Vyzkum_a_vyuka_mediciny_v_Olomouci_na_nove_urovni.php weekly 0.7 /artkey/xon-201206-0014_ESMO-European_Society_for_Medical_Oncology_Viden_28_zari-2_rijna_2012.php weekly 0.7 /artkey/xon-201206-0002_Invazivne_mykoticke_infekcie_u_hematoonkologickych_pacientov-epidemiologia_rizikove_faktory_kli.php weekly 0.7 /artkey/xon-201206-0003_Antimykoticka_lecba_invazivnich_mykoz_imunosuprimovanych_nemocnych.php weekly 0.7 /artkey/xon-201206-0004_Vorikonazol_a_vyznam_mereni_jeho_plazmatickych_koncentraci_v_prubehu_antimykoticke_lecby.php weekly 0.7 /magno/xon/2011/mn1.php weekly 0.7 /artkey/xon-201101-0001_Spolecnost_gastrointestinalni_onkologie.php weekly 0.7 /artkey/xon-201101-0009_Prognosticke_a_prediktivni_faktory_u_pacientu_s_metastatickym_karcinomem_ledviny_lecene_cilenou_t.php weekly 0.7 /artkey/xon-201101-0010_zaraUloha_stereotakticke_biopsie_v_diagnostice_tumoru_mozku.php weekly 0.7 /artkey/xon-201101-0013_Autodidakticky_test_1_2011.php weekly 0.7 /artkey/xon-201101-0011_Cetuximab_v_kombinaci_s_radioterapii_jako_metoda_volby_v_prvni_linii_lecby_lokoregionalne_pokrocil.php weekly 0.7 /artkey/xon-201101-0012_Dlouhodoba_terapeuticka_ucinnost_cetuximabu_v_lecbe_metastazujiciho_kolorektalniho_karcinomu_po_s.php weekly 0.7 /artkey/xon-201101-0002_Karcinom_prsu-slovo_uvodem.php weekly 0.7 /artkey/xon-201101-0003_Screening_nadoru_prsu_v_Ceske_republice_Vysledky_fungovani_akreditovanych_mamodiagnostickych_scr.php weekly 0.7 /artkey/xon-201101-0004_Biopsie_sentinelove_uzliny_u_zen_s_casnym_karcinomem_prsu.php weekly 0.7 /artkey/xon-201101-0005_Antracykliny_v_lecbe_metastatickeho_karcinomu_prsu.php weekly 0.7 /artkey/xon-201101-0006_Novinky_v_cilene_lecbe_karcinomu_prsu.php weekly 0.7 /artkey/xon-201101-0007_Moznosti_preventivnich_opatreni_u_nosicu_mutaci_genu_BRCA1_a_BRCA2.php weekly 0.7 /artkey/xon-201101-0008_Paliativni_analgeticka_terapie_kostnich_metastaz_186Rheniem-HEDP.php weekly 0.7 /magno/xon/2011/mn2.php weekly 0.7 /artkey/xon-201102-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201102-0007_Klinicky_obraz_a_soucasne_moznosti_lecby_prulomove_bolesti_u_onkologickych_pacientu.php weekly 0.7 /artkey/xon-201102-0008_Akutni_myeloidni_leukemie_u_nemocnych_nad_60_let_moznosti_jeji_lecby_a_potencialni_role_alogenni.php weekly 0.7 /artkey/xon-201102-0009_Osteosarkom_soucasne_moznosti_diagnostiky_a_lecby.php weekly 0.7 /artkey/xon-201102-0010_Role_cetuximabu_ve_2_linii_terapie_metastatickeho_kolorektalniho_karcinomu_s_naslednou_udrzovaci.php weekly 0.7 /artkey/xon-201102-0011_Role_cetuximabu_v_dlouhodobem_prezivani_pacienta_s_metastatickym_kolorektalnim_karcinomem.php weekly 0.7 /artkey/xon-201102-0012_Pece_o_komplikovany_lymfedem_provazejici_specificke_malignity_zen-vybrane_kazuistiky.php weekly 0.7 /artkey/xon-201102-0013_ZENITH_meeting_2011_Berlin_28_-29_ledna.php weekly 0.7 /artkey/xon-201102-0014_3rd_International_Conference_on_Innovative_Approaches_in_Head_Neck_Oncology_Barcelona_24_-26.php weekly 0.7 /artkey/xon-201102-0015_Prubeh_a_zavery_mezioboroveho_setkani_8222_Winter_GLIO_TRACK_Meeting_8220_2011.php weekly 0.7 /artkey/xon-201102-0002_Nadory_centralniho_nervoveho_systemu-slovo_uvodem.php weekly 0.7 /artkey/xon-201102-0003_Neurochirurgicka_lecba_mozkovych_nadoru.php weekly 0.7 /artkey/xon-201102-0004_Nechirurgicka_terapie_malignich_gliomu.php weekly 0.7 /artkey/xon-201102-0005_Stereotakticka_radiochirurgie_a_radioterapie_gama_nozem.php weekly 0.7 /artkey/xon-201102-0006_Moznosti_stereotaktickeho_ozareni_patere_a_michy_pristrojem_CyberKnife.php weekly 0.7 /artkey/xon-201102-0016_Autodidakticky_test_2_2011.php weekly 0.7 /artkey/xon-201102-0017_Detska_onkologie_z_pohledu_osetrujici_sestry.php weekly 0.7 /magno/xon/2011/mn3.php weekly 0.7 /artkey/xon-201103-0001_XXV_olomoucke_hematologicke_dny.php weekly 0.7 /artkey/xon-201103-0010_Diabetes_mellitus_a_zhoubny_nador.php weekly 0.7 /artkey/xon-201103-0011_Hormonalni_terapie_pacientek_s_nadory_prsu_z_pohledu_gynekologa.php weekly 0.7 /artkey/xon-201103-0012_Vicecetne_nadory_nervoveho_systemu_a_dalsi_primarni_novotvary.php weekly 0.7 /artkey/xon-201103-0013_Vyznam_cilene_lecby_solidnich_nadoru_na_prikladu_kazuistiky_podani_cetuximabu_v_terapii_kolorekta.php weekly 0.7 /artkey/xon-201103-0014_Hepatoblastom_v_dospelosti-pacient_s_dlouholetou_kontrolou_nemoci_multimodalni_lecbou.php weekly 0.7 /artkey/xon-201103-0002_Mnohocetny_myelom-slovo_uvodem.php weekly 0.7 /artkey/xon-201103-0003_Soucasne_moznosti_diagnostiky_myelomove_kostni_nemoci.php weekly 0.7 /artkey/xon-201103-0004_RMG-Registr_Monoklonalnich_Gamapatii.php weekly 0.7 /artkey/xon-201103-0005_Zkusenosti_s_pouzivanim_bortezomibu_Velcade_v_Ceske_republice_od_roku_2004.php weekly 0.7 /artkey/xon-201103-0006_Prognoza_vysoko_rizikovej_skupiny_monoklonalnej_gamapatie_nejasneho_vyznamu_MGUS_a_asymptomatic.php weekly 0.7 /artkey/xon-201103-0007_POEMS_syndrom.php weekly 0.7 /artkey/xon-201103-0008_Pouziti_perkutanni_vertebroplastiky_u_pacientu_s_mnohocetnym_myelomem-zkusenosti_jednoho_centra.php weekly 0.7 /artkey/xon-201103-0009_Profylaxe_a_lecba_tromboembolicke_nemoci_u_pacientu_s_mnohocetnym_myelomem.php weekly 0.7 /artkey/xon-201103-0015_Autodidakticky_test_3_2011.php weekly 0.7 /magno/xon/2011/mn4.php weekly 0.7 /artkey/xon-201104-0001_Jak_klikata_je_cesta_onkologickeho_pacienta_k_onkologovi.php weekly 0.7 /artkey/xon-201104-0006_Screening_a_vcasny_zachyt_kolorektalniho_karcinomu-soucasny_stav_v_jednotlivych_krajich_Ceske_rep.php weekly 0.7 /artkey/xon-201104-0007_Terapie_kolorektalniho_karcinomu-stav_v_roce_2011.php weekly 0.7 /artkey/xon-201104-0008_Cetuximab_rozsiruje_lecebne_moznosti_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-201104-0009_Multidisciplinarni_pristup_v_lecbe_gastrointestinalnich_stromalnich_nadoru.php weekly 0.7 /artkey/xon-201104-0010_Ph_pozitivni_akutni_lymfoblasticka_leukemie_dospelych.php weekly 0.7 /artkey/xon-201104-0011_Primarni_rasinky_a_jejich_biologicke_funkce.php weekly 0.7 /artkey/xon-201104-0012_Kurativni_radioterapie_v_kombinaci_s_cetuximabem_jako_organ_zachovny_zpusob_lecby_u_pokrocileho_kar.php weekly 0.7 /artkey/xon-201104-0013_Cetuximab_v_kombinaci_s_irinotecanem_podavany_1_1093_za_2_tydny_u_pacientky_s_generalizovanym_kar.php weekly 0.7 /artkey/xon-201104-0015_2011_International_Multinational_Association_of_Supportive_Care_in_Cancer_International_Society_for.php weekly 0.7 /artkey/xon-201104-0002_Karcinom_ledviny-slovo_uvodem.php weekly 0.7 /artkey/xon-201104-0003_Soucasny_pohled_na_strategii_lecby_metastatickeho_karcinomu_ledviny.php weekly 0.7 /artkey/xon-201104-0004_Cilena_lecba_karcinomu_ledviny.php weekly 0.7 /artkey/xon-201104-0005_Cytokiny_v_lecbe_metastatickeho_karcinomu_ledviny_minulost_a_soucasnost.php weekly 0.7 /artkey/xon-201104-0016_Autodidakticky_test_4_2011.php weekly 0.7 /artkey/xon-201104-0014_Biopsychosocialni_model_onkologickeho_onemocneni.php weekly 0.7 /magno/xon/2011/mn5.php weekly 0.7 /artkey/xon-201105-0003_O_novych_nemocech_z_povolani.php weekly 0.7 /artkey/xon-201105-0011_Zhoubne_nadory_jako_nemoci_z_povolani_v_Ceske_republice_v_letech_1991_az_2009.php weekly 0.7 /artkey/xon-201105-0012_Vyznam_stomatologicke_pripravy_hematoonkologickeho_pacienta_pred_transplantaci_krvetvornych_bunek.php weekly 0.7 /artkey/xon-201105-0013_Redukce_toxicity_primarni_lecby_pokrocileho_Hodgkinova_lymfomu.php weekly 0.7 /artkey/xon-201105-0014_Role_cetuximabu_v_lecbe_metastatickeho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201105-0016_Cetuximab_v_lecbe_lokalne_pokrocilych_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-201105-0020_Antibodies_in_relation_to_oncology.php weekly 0.7 /artkey/xon-201105-0021_ECCO_16_ESMO_36_ESTRO_30_Stockholm_2011.php weekly 0.7 /artkey/xon-201105-0004_Kolorektalni_karcinom-slovo_uvodem.php weekly 0.7 /artkey/xon-201105-0005_Epidemiologie_etiologie_screening_a_diagnostika_kolorektalniho_karcinomu_vcetne_diagnosticko-ter.php weekly 0.7 /artkey/xon-201105-0006_Zobrazovaci_metody_v_diagnostice_a_lecbe_kolorektalniho_karcinomu_vcetne_intervencnich_metod.php weekly 0.7 /artkey/xon-201105-0007_Chirurgicka_a_miniinvazivni_lecba_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201105-0008_Radikalita_resekce_jater_a_moderni_postupy_ke_zvyseni_resekability_u_nemocnych_s_jaternimi_metastaz.php weekly 0.7 /artkey/xon-201105-0009_Chemoterapie_a_biologicka_lecba_kolorektalniho_karcinomu_s_cilem_operability_primarne_inoperabilnih.php weekly 0.7 /artkey/xon-201105-0010_Konkomitantni_chemoradioterapie_nadoru_rekta.php weekly 0.7 /artkey/xon-201105-0015_Jak_spravne_informovat_pacienta.php weekly 0.7 /artkey/xon-201105-0022_Autodidakticky_test_5_2011.php weekly 0.7 /artkey/xon-201105-0017_Poprve_v_CR_Hypertermicka_izolovana_perfuze_koncetin_s_pouzitim_tasonerminu_v_lecbe_nadoru_mekkych.php weekly 0.7 /artkey/xon-201105-0018_Vysledky_studie_kterou_prave_uverejnil_New_England_Journal_of_Medicine_prokazuji_ze_vyzkumna_lat.php weekly 0.7 /artkey/xon-201105-0019_Novartis_drug_Afinitor_174_helps_women_with_advanced_breast_cancer_live_significantly_longer_with.php weekly 0.7 /magno/xon/2011/mn6.php weekly 0.7 /artkey/xon-201106-0001_Vyznam_bibliografi_ckych_databazi_v_onkologii_a_postaveni_casopisu_Onkologie.php weekly 0.7 /artkey/xon-201106-0008_Lokalni_chemoprofylaxe_Mitomycinem_C_u_stredne_a_vysokorizikovych_neinvazivnich_nadoru_mocoveho_mec.php weekly 0.7 /artkey/xon-201106-0009_Multidisciplinarni_pristup_v_radikalni_lecbe_nemocnych_s_jaternimi_metastazami_kolorektalniho_karci.php weekly 0.7 /artkey/xon-201106-0010_Neuroendokrinni_nadory.php weekly 0.7 /artkey/xon-201106-0011_Nadory_ledvin_u_deti_adolescentu_a_mladych_dospelych_Rozdily_v_biologii_napric_vekovym_spektrem.php weekly 0.7 /artkey/xon-201106-0012_Hyperfrakcionovana_radioterapie_70-75_Gy_za_5_tydnu_s_konkomitantnim_podanim_cetuximabu_u_pokrocily.php weekly 0.7 /artkey/xon-201106-0014_2011_European_Multidisciplinary_Cancer_Congress_Stockholm.php weekly 0.7 /artkey/xon-201106-0015_Novinky_ze_sveta_cetuximabu.php weekly 0.7 /artkey/xon-201106-0016_Jak_prospiva_stridme_piti_vina_lidskemu_zdravi.php weekly 0.7 /artkey/xon-201106-0002_Karcinomy_stitne_zlazy-slovo_uvodem.php weekly 0.7 /artkey/xon-201106-0003_Genetika_nadoru_stitne_zlazy_a_jejich_molekularne_cilena_lecba.php weekly 0.7 /artkey/xon-201106-0004_Diferencovany_karcinom_stitne_zlazy-novy_pohled_na_jeho_lecbu.php weekly 0.7 /artkey/xon-201106-0005_Funkcni_zobrazeni_a_lecba_neuroendokrinnich_tumoru_pomoci_metajodbenzylguanidinu.php weekly 0.7 /artkey/xon-201106-0006_Medularni_karcinom_stitne_zlazy-diagnosticke_a_lecebne_moznosti.php weekly 0.7 /artkey/xon-201106-0007_Ocekavane_pocty_karcinomu_stitne_zlazy_ve_svete.php weekly 0.7 /artkey/xon-201106-0017_Autodidakticky_test_6_2011.php weekly 0.7 /artkey/xon-201106-0013_Diky_novemu_pruzkumu_zadaji_odbornici_po_celem_svete_zlepseni_edukace_zvyseni_povedomi_a_podpory_p.php weekly 0.7 /magno/xon/2010/mn1.php weekly 0.7 /artkey/xon-201001-0001_Jak_pecovat_o_pacienta_ktery_nema_domov.php weekly 0.7 /artkey/xon-201001-0006_Biologicka_liecba_u_seniorov.php weekly 0.7 /artkey/xon-201001-0007_Postaveni_neoadjuvantni_chemoterapie_u_jaternich_metastaz_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-201001-0008_Aktuality_o_preparatech_stimulujicich_erytropoezu_a_klinickych_studiich_v_onkologii.php weekly 0.7 /artkey/xon-201001-0009_Antiangiogenna_terapia_v_onkologii.php weekly 0.7 /artkey/xon-201001-0010_Duplicita_primarnich_mozkovych_nadoru.php weekly 0.7 /artkey/xon-201001-0011_Erlotinib_v_lecbe_metastatickeho_karcinomu_slinivky_brisni-nase_zkusenosti.php weekly 0.7 /artkey/xon-201001-0012_ZENITH_Meeting_2010.php weekly 0.7 /artkey/xon-201001-0013_Prubeh_a_zavery_mezioboroveho_setkani_8222_Winter_GLIO_TRACK_Meeting_8221_2010.php weekly 0.7 /artkey/xon-201001-0002_GIST-slovo_uvodem.php weekly 0.7 /artkey/xon-201001-0003_Chirurgicka_lecba_gastrointestinalnich_stromalnich_nadoru.php weekly 0.7 /artkey/xon-201001-0004_Patologicka_diagnostika_gastrointestinalniho_stromalniho_tumoru.php weekly 0.7 /artkey/xon-201001-0005_Lecba_pokrocileho_gastrointestinalniho_stromalniho_nadoru.php weekly 0.7 /artkey/xon-201001-0014_Autodidakticky_test_1_2010.php weekly 0.7 /artkey/xon-201001-0015_Evropska_unie_schvalila_lek_Herceptin_k_lecbe_HER2-pozitivniho_metastazujiciho_karcinomu_zaludku.php weekly 0.7 /artkey/xon-201001-0016_Roche_investuje_priblizne_190_milionu_svycarskych_franku_do_systemu_jez_umoznuje_aby_byl_lecivy.php weekly 0.7 /magno/xon/2010/mn2.php weekly 0.7 /artkey/xon-201002-0001_Cesky_den_proti_rakovine.php weekly 0.7 /artkey/xon-201002-0009_Prulomova_bolest_a_jeji_lecba.php weekly 0.7 /artkey/xon-201002-0010_Lecba_anemie_erytropoezu_stimulujicimi_proteiny_u_pacientu_s_myelodysplastickym_syndromem.php weekly 0.7 /artkey/xon-201002-0011_Faslodex_500_a_nove_moznosti_lecby.php weekly 0.7 /artkey/xon-201002-0012_Antracykliny_v_lecbe_karcinomu_prsu_pro_a_proti.php weekly 0.7 /artkey/xon-201002-0013_Testovani_HER-2_neu_u_karcinomu_zaludku-nova_vyzva_i_nadeje.php weekly 0.7 /artkey/xon-201002-0014_Akutni_leukemie_u_deti.php weekly 0.7 /artkey/xon-201002-0015_Vysledky_dlouhodobe_klinicke_studie_prodlouzeni_preziti_u_pacientu_s_metastatickym_karcinomem_pr.php weekly 0.7 /artkey/xon-201002-0016_Sorafenib_je_ucinny_v_sekvencni_terapii_metastatickeho_renalniho_karcinomu.php weekly 0.7 /artkey/xon-201002-0020_Autodidakticky_test_2_2010.php weekly 0.7 /artkey/xon-201002-0019_Avastin_v_lecbe_nemalobunecne_plicni_rakoviny.php weekly 0.7 /artkey/xon-201002-0002_Karcinom_prostaty-slovo_uvodem.php weekly 0.7 /artkey/xon-201002-0003_Soucasne_trendy_diagnostiky_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201002-0004_Radikalni_prostatektomie.php weekly 0.7 /artkey/xon-201002-0005_Brachyterapie_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201002-0006_Moderni_trendy_v_radioterapii_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201002-0007_Novinky_v_lecbe_karcinomu_prostaty-cilena_lecba_hormonalne_refrakterniho_karcinomu_prostaty.php weekly 0.7 /artkey/xon-201002-0008_Dalsi_primarni_novotvary_u_nemocnych_s_karcinomem_prostaty_ve_srovnani_s_jeho_incidenci_mortalit.php weekly 0.7 /artkey/xon-201002-0017_Komentar_k_clanku_Sorafenib_je_ucinny_v_sekvencni_terapii_metastatickeho_renalniho_karcinomu.php weekly 0.7 /artkey/xon-201002-0018_Lapatinib_kombinovany_s_letrozolem_proti_letrozolu_v_kombinaci_s_placebem_v_prvni_linii_terapie_hor.php weekly 0.7 /magno/xon/2010/mn3.php weekly 0.7 /artkey/xon-201003-0001_24_olomoucke_hematologicke_dny.php weekly 0.7 /artkey/xon-201003-0008_Soucasny_pohled_na_adjuvantni_hormonalni_lecbu_premenopauzalnich_pacientek_s_karcinomem_prsu.php weekly 0.7 /artkey/xon-201003-0009_Lecba_bolesti_ionizujicim_zarenim_u_pacientu_s_karcinomem_prsu_a_kostnimi_metastazami.php weekly 0.7 /artkey/xon-201003-0010_Lecba_recidiv_karcinomu_delozniho_hrdla.php weekly 0.7 /artkey/xon-201003-0011_Bevacizumab_soucasne_postaveni_v_lecbe_solidnich_nadoru.php weekly 0.7 /artkey/xon-201003-0012_Novy_mechanizmus_v_lecbe_karcinomu_ledviny_m-TOR-nova_cilova_struktura.php weekly 0.7 /artkey/xon-201003-0013_Lecba_chronicke_myeloidni_leukemie_u_dospelych_v_roce_2010.php weekly 0.7 /artkey/xon-201003-0014_Udrzovaci_lecba_rituximabem_u_ne-Hodgkinovych_lymfomu-moznosti_v_roce_2010.php weekly 0.7 /artkey/xon-201003-0018_Autodidakticky_test_3_2010.php weekly 0.7 /artkey/xon-201003-0015_Antiangiogenni_lecba_metastatickeho_kolorektalniho_karcinomu-analyza_dat_z_dvou_center.php weekly 0.7 /artkey/xon-201003-0016_Histiocytoza_z_Langerhansovych_bunek_v_ORL_oblasti.php weekly 0.7 /artkey/xon-201003-0017_EHNS-European_Conference_on_Head_and_Neck_Oncology_Ateny_3_-6_brezna_2010.php weekly 0.7 /artkey/xon-201003-0002_Hodgkinuv_lymfom-slovo_uvodem.php weekly 0.7 /artkey/xon-201003-0003_Vysetrovaci_metody_a_prognosticke_faktory_u_Hodgkinova_lymfomu.php weekly 0.7 /artkey/xon-201003-0004_Soucasne_nazory_na_lecbu_Hodgkinova_lymfomu.php weekly 0.7 /artkey/xon-201003-0005_Ochrana_reprodukce_u_nemocnych_s_Hodgkinovym_lymfomem.php weekly 0.7 /artkey/xon-201003-0006_Lecba_Hodgkinova_lymfomu_v_tehotenstvi.php weekly 0.7 /artkey/xon-201003-0007_Pozdni_nasledky_lecby_Hodgkinova_lymfomu.php weekly 0.7 /magno/xon/2010/mn4.php weekly 0.7 /artkey/xon-201004-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-201004-0008_Lidsky_papillomavirus_z_pohledu_onkologie.php weekly 0.7 /artkey/xon-201004-0009_Imunologicky_profil_pacientov_s_chronickou_myelozou_liecenych_inhibitormi_tyrozinovych_kinaz-li.php weekly 0.7 /artkey/xon-201004-0010_Zmeny_ve_screeningu_kolorektalniho_karcinomu-krok_spravnym_smerem.php weekly 0.7 /artkey/xon-201004-0011_Meduloblastom_nejcastejsi_zhoubny_nador_mozku_u_deti.php weekly 0.7 /artkey/xon-201004-0016_Autodidakticky_test_4_2010.php weekly 0.7 /artkey/xon-201004-0013_Prvni_zkusenosti_s_lecbou_bolesti_pri_orofaryngealni_mukozitide_pomoci_transdermalniho_buprenorfi.php weekly 0.7 /artkey/xon-201004-0014_Klinicke_zkusenosti_s_lecbou_erlotinibem_u_nemocnych_s_pokrocilym_nemalobunecnym_bronchogennim_ka.php weekly 0.7 /artkey/xon-201004-0015_Necekana_diagnoza_u_trinactilete_pacientky_s_brisni_lymfadenopatii_a_B_symptomy.php weekly 0.7 /artkey/xon-201004-0002_Kozni_nadory-slovo_uvodem.php weekly 0.7 /artkey/xon-201004-0003_Maligni_melanom.php weekly 0.7 /artkey/xon-201004-0004_Nejcastejsi_maligni_epitelove_kozni_nadory.php weekly 0.7 /artkey/xon-201004-0005_Primarni_kozni_T-lymfomy_mycosis_fungoides_a_Sezaryho_syndrom.php weekly 0.7 /artkey/xon-201004-0006_Kozni_metastazy.php weekly 0.7 /artkey/xon-201004-0007_Kozni_metastazy_karcinomu_ovaria.php weekly 0.7 /artkey/xon-201004-0012_Vysledky_chirurgickej_liecby_plucnych_metastaz.php weekly 0.7 /magno/xon/2010/mn5.php weekly 0.7 /artkey/xon-201005-0001_Smysl_zivota_ve_stari.php weekly 0.7 /artkey/xon-201005-0007_Uloha_pemetrexedu_v_lecbe_rakoviny_plic.php weekly 0.7 /artkey/xon-201005-0008_Nadory_plexus_choroideus_u_deti_a_adolescentu.php weekly 0.7 /artkey/xon-201005-0009_Adjuvantni_terapie_imatinibem_u_gastrointestinalnich_stromalnich_tumoru.php weekly 0.7 /artkey/xon-201005-0010_Zatez_nadory_pankreatu_u_ceske_populace.php weekly 0.7 /artkey/xon-201005-0013_Autodidakticky_test_5_2010.php weekly 0.7 /artkey/xon-201005-0011_Farmakogenomicka_predikce_ucinnosti_tamoxifenu_v_lecbe_hormonalne_dependentnich_postmenopauzalnic.php weekly 0.7 /artkey/xon-201005-0012_Kongres_ESMO_2010.php weekly 0.7 /artkey/xon-201005-0002_Sarkomy_mekkych_tkani-slovo_uvodem.php weekly 0.7 /artkey/xon-201005-0003_Histopatologicka_diagnostika_nadoru_mekkych_tkani.php weekly 0.7 /artkey/xon-201005-0004_Chirurgicke_aspekty_lecby_sarkomu_mekkych_tkani.php weekly 0.7 /artkey/xon-201005-0005_Role_radioterapie_v_lecbe_sarkomu_mekkych_tkani.php weekly 0.7 /artkey/xon-201005-0006_Systemova_lecba_sarkomu_mekkych_tkani_dospelych_vyjma_GIST.php weekly 0.7 /magno/xon/2010/mn6.php weekly 0.7 /artkey/xon-201006-0001_Adventni_rozjimani.php weekly 0.7 /artkey/xon-201006-0007_Prinos_pocitacove_tomografie_a_magneticke_rezonance_ve_stanoveni_rozsahu_nadoroveho_onemocneni_v.php weekly 0.7 /artkey/xon-201006-0008_Soucasny_pohled_na_chirurgickou_lecbu_DCIS.php weekly 0.7 /artkey/xon-201006-0009_Klinicka_stadia_u_nemocnych_s_vicecetnymi_novotvary.php weekly 0.7 /artkey/xon-201006-0012_Autodidakticky_test_6_2010.php weekly 0.7 /artkey/xon-201006-0010_Desmoplasticky_kulatobunecny_tumor.php weekly 0.7 /artkey/xon-201006-0011_Kongres_ESMO_2010_nadory_hlavy_a_krku.php weekly 0.7 /artkey/xon-201006-0002_Karcinom_pankreatu-slovo_uvodem.php weekly 0.7 /artkey/xon-201006-0003_Karcinom_pankreatu_Chirurgicka_strategie_lecby.php weekly 0.7 /artkey/xon-201006-0004_Chirurgie_karcinomu_hlavy_pankreatu_hodnoceni_prezivani.php weekly 0.7 /artkey/xon-201006-0005_Synchronni_invazivni_duktalni_adenokarcinomy_pankreatu_a_jejich_klinicky_vyznam.php weekly 0.7 /artkey/xon-201006-0006_Neuroendokrinni_nadory_pankreatu-pohled_chirurga.php weekly 0.7 /magno/xon/2009/mn1.php weekly 0.7 /artkey/xon-200901-0001_Karcinom_prsu-uvodem.php weekly 0.7 /artkey/xon-200901-0007_Lymfadenektomie_a_detekce_sentinelove_uzliny_u_karcinomu_zaludku.php weekly 0.7 /artkey/xon-200901-0008_Fertilitu_zachovavajici_postupy_u_casnych_stadii_karcinomu_delozniho_hrdla.php weekly 0.7 /artkey/xon-200901-0009_Moznosti_lecby_bolesti_pri_orofaryngealni_mukozitide_a_role_transdermalnich_opioidu.php weekly 0.7 /artkey/xon-200901-0010_Soucasne_moznosti_laboratorniho_vysetrovani_pro_onkologicky_nemocne_2_cast.php weekly 0.7 /artkey/xon-200901-0011_Karcinom_prsu_a_nasledne_primarni_zhoubne_novotvary_v_Ceske_republice_1976-2005.php weekly 0.7 /artkey/xon-200901-0012_Prevence_osteonekrozy_celisti_pred_onkologickou_lecbou.php weekly 0.7 /artkey/xon-200901-0013_Pokrocily_germinalni_tumor_varlete_u_dospivajiciho_chlapce.php weekly 0.7 /artkey/xon-200901-0015_IV_dny_diagnosticke_prediktivni_a_experimentalni_onkologie_a_I_sympozium_o_cilene_biologicke_lec.php weekly 0.7 /artkey/xon-200901-0002_Strucny_prehled_epidemiologie_zhoubneho_novotvaru_prsu_v_Ceske_republice.php weekly 0.7 /artkey/xon-200901-0003_Chemoterapie_a_hormonalni_lecba_karcinomu_prsu.php weekly 0.7 /artkey/xon-200901-0004_Biologicka_lecba_karcinomu_prsu.php weekly 0.7 /artkey/xon-200901-0005_Radioterapie_karcinomu_prsu.php weekly 0.7 /artkey/xon-200901-0006_Lymfedem-komplikace_komplexni_lecby_karcinomu_prsu.php weekly 0.7 /artkey/xon-200901-0014_Autodidakticky_test_1_2009.php weekly 0.7 /magno/xon/2009/mn2.php weekly 0.7 /artkey/xon-200902-0001_Zalozeni_Ceske_spolecnosti_paliativni_mediciny.php weekly 0.7 /artkey/xon-200902-0009_Kvalita_zivota_pacienta_pri_podavani_peroralni_onkologicke_lecby.php weekly 0.7 /artkey/xon-200902-0010_Bisfosfonaty_v_lecbe_metastatickeho_kostniho_postizeni.php weekly 0.7 /artkey/xon-200902-0011_Zasady_osetrovani_v_dutine_ustni_u_nemocnych_lecenych_bisfosfonaty.php weekly 0.7 /artkey/xon-200902-0012_Uziti_cytokinu_v_lecbe_metastazujiciho_renalniho_karcinomu_ve_stinu_biologicke_lecby.php weekly 0.7 /artkey/xon-200902-0013_Soucasne_moznosti_laboratorniho_vysetrovani_pro_onkologicky_nemocne_3_cast.php weekly 0.7 /artkey/xon-200902-0014_Metastaza_karcinomu_prsu_v_rektu.php weekly 0.7 /artkey/xon-200902-0002_Ohlednuti_za_pokroky_v_lecbe_metastatickeho_karcinomu_ledviny.php weekly 0.7 /artkey/xon-200902-0003_Karcinom_ledvin_dospelych.php weekly 0.7 /artkey/xon-200902-0004_Farmakoterapie_metastatickeho_karcinomu_ledviny.php weekly 0.7 /artkey/xon-200902-0005_Zobrazovaci_metody_v_diagnostice_a_lecbe_renalniho_karcinomu_vcetne_intervencnich_metod.php weekly 0.7 /artkey/xon-200902-0006_Postaveni_radioterapie_v_lecebne_strategii_karcinomu_ledviny.php weekly 0.7 /artkey/xon-200902-0007_Chirurgicka_lecba_nadoru_ledvin.php weekly 0.7 /artkey/xon-200902-0008_Molekularni_biologie_karcinomu_ledviny.php weekly 0.7 /artkey/xon-200902-0017_Autodidakticky_test_2_2009.php weekly 0.7 /artkey/xon-200902-0016_Mukozitida_dutiny_ustni_pri_radioterapii_v_oblasti_hlavy_a_krku.php weekly 0.7 /magno/xon/2009/mn3.php weekly 0.7 /artkey/xon-200903-0001_Poslani.php weekly 0.7 /artkey/xon-200903-0008_Nutricni_podpora_nemocnych_s_transplantaci_krvetvornych_bunek.php weekly 0.7 /artkey/xon-200903-0009_Vyznam_chemoterapie_u_karcinomu_jicnu.php weekly 0.7 /artkey/xon-200903-0010_Nasledne_primarni_novotvary_u_125_262_onkologicky_nemocnychv_Ceske_republice_1976-2005.php weekly 0.7 /artkey/xon-200903-0011_Efekt_neoadjuvantne_podaneho_Herceptinu_reg_trastuzumabu_u_pacientky_s_karcinomem_prsu_s_vysokou.php weekly 0.7 /artkey/xon-200903-0012_Moznosti_neuroendoskopie_v_komplexni_terapii_kraniofaryngeomu.php weekly 0.7 /artkey/xon-200903-0013_ICHNO-2nd_International_Conference_on_Innovative_Approaches_in_Head_and_Neck_Oncology_Barcelona_2.php weekly 0.7 /artkey/xon-200903-0002_Ne-hodgkinovy_lymfomy-slovo_uvodem.php weekly 0.7 /artkey/xon-200903-0003_Epidemiologie_ne-hodgkinovych_lymfomu_v_Ceske_republice_Evrope_a_Severni_Americe.php weekly 0.7 /artkey/xon-200903-0004_Aktualni_pohled_na_diagnostiku_a_lecbu_folikularniho_lymfomu.php weekly 0.7 /artkey/xon-200903-0005_Soucasne_moznosti_lecby_mladsich_dospelych_pacientu_s_difuznim_velkobunecnym_B-lymfomem.php weekly 0.7 /artkey/xon-200903-0006_Jak_pristupovat_k_lecbe_starsich_nemocnych_s_difuznim_velkobunecnym_B-lymfomem.php weekly 0.7 /artkey/xon-200903-0007_Soucasne_moznosti_pozitronove_emisni_tomografie_a_integrovane_pozitronove_emisni_tomografie_s_pocit.php weekly 0.7 /artkey/xon-200903-0014_Autodidakticky_test_3_2009.php weekly 0.7 /magno/xon/2009/mn4.php weekly 0.7 /artkey/xon-200904-0001_Podpurna_pece_jako_integralni_soucast_individualizovane_onkologicke_lecby.php weekly 0.7 /artkey/xon-200904-0007_Diagnostika_a_liecba_invazivnych_mykoz_u_hematoonkologickych_pacientov.php weekly 0.7 /artkey/xon-200904-0008_Sorafenib_v_lecbe_generalizovaneho_maligniho_melanomu_prehled_klinickych_studii.php weekly 0.7 /artkey/xon-200904-0009_Nektere_aspekty_kombinovane_lecby_panevnich_nadoru.php weekly 0.7 /artkey/xon-200904-0010_Vyuziti_doplnkove_enteralni_vyzivy_behem_hospitalizace.php weekly 0.7 /artkey/xon-200904-0011_Toxoplazmova_infekce_centralniho_nervoveho_systemu_u_nemocne_v_dlouhodobe_remisi_Hodgkinova_lymfomu.php weekly 0.7 /artkey/xon-200904-0012_Avaskularni_nekroza_hlavice_kosti_stehenni_u_pacientky_s_difuznim_velkobunecnym_B-lymfomem_lecenym.php weekly 0.7 /artkey/xon-200904-0014_Novinky_z_ASCO_2009-vyber_nejzajimavejsich_prezentaci.php weekly 0.7 /artkey/xon-200904-0002_Detska_onkologie-slovo_uvodem.php weekly 0.7 /artkey/xon-200904-0003_Manozu_vazajici_lektin_u_detskych_onkologickych_pacientu.php weekly 0.7 /artkey/xon-200904-0004_S_infuzi_spojena_akutni_nezadouci_reakce_ruznych_lekovych_forem_Amphotericinu_B.php weekly 0.7 /artkey/xon-200904-0005_Renalni_toxicita_vysokych_davek_ifosfamidu_u_pacientu_s_Ewingovym_sarkomem_PNET.php weekly 0.7 /artkey/xon-200904-0006_Metronomicka_lecba_v_onkologii_jako_nova_lecebna_metoda.php weekly 0.7 /artkey/xon-200904-0015_Autodidakticky_test_4_09.php weekly 0.7 /artkey/xon-200904-0013_Sdelovani_pravdy_o_zdravotnim_stavu.php weekly 0.7 /magno/xon/2009/mn5.php weekly 0.7 /artkey/xon-200905-0001_Lekar_ktery_se_nepostara_sam_o_sebe_neni_zarukou_dobre_pece_o_pacienta.php weekly 0.7 /artkey/xon-200905-0008_Cetuximab_a_irinotecan_v_lecbe_chemorezistentniho_metastazujiciho_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-200905-0009_Bisfosfonaty_u_nemocnych_s_karcinomem_plic_a_kostnimi_metastazami.php weekly 0.7 /artkey/xon-200905-0010_Dosavadni_zkusenosti_s_lecbou_lenalidomidem_u_pacientu_s_mnohocetnym_myelomem_v_CR-pilotni_data_u.php weekly 0.7 /artkey/xon-200905-0002_Karcinom_plic-doba_pomalych_ale_optimistickych_promen.php weekly 0.7 /artkey/xon-200905-0003_Chirurgicka_lecba_rakoviny_plic.php weekly 0.7 /artkey/xon-200905-0004_Misto_radioterapie_v_lecbe_karcinomu_plic.php weekly 0.7 /artkey/xon-200905-0005_Postaveni_chemoterapie_v_lecbe_karcinomu_plic.php weekly 0.7 /artkey/xon-200905-0006_Biologicka_lecba_nemalobunecneho_karcinomu_plic.php weekly 0.7 /artkey/xon-200905-0007_Bronchogenni_karcinom_a_jeho_prognosticke_a_prediktivni_faktory.php weekly 0.7 /artkey/xon-200905-0013_Autodidakticky_test_5_09.php weekly 0.7 /artkey/xon-200905-0011_Prevence_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-200905-0012_Informacni_technologie-uskali_a_pasti_1_dil.php weekly 0.7 /magno/xon/2009/mn6.php weekly 0.7 /artkey/xon-200906-0001_Slovo_uvodem.php weekly 0.7 /artkey/xon-200906-0007_Screening_karcinomu_prostaty.php weekly 0.7 /artkey/xon-200906-0008_Intervencni_vykony_v_diagnostice_nemoci_prsni_zlazy.php weekly 0.7 /artkey/xon-200906-0009_Raritny_pripad_mezenterialnej_fibromatozy.php weekly 0.7 /artkey/xon-200906-0010_Problematika_zakladni_prevence_a_screeningu_nadorovych_onemocneni_v_praxi_praktickeho_lekare.php weekly 0.7 /artkey/xon-200906-0011_V_dny_diagnosticke_prediktivni_a_experimentalni_onkologie_a_II_sympozium_o_biologicke_lecbe_prop.php weekly 0.7 /artkey/xon-200906-0002_Vzacne_nadory.php weekly 0.7 /artkey/xon-200906-0003_Maligni_thymom-nase_zkusenosti_s_terapii_92_nemocnych.php weekly 0.7 /artkey/xon-200906-0004_Karcinoidy.php weekly 0.7 /artkey/xon-200906-0005_Feochromocytom.php weekly 0.7 /artkey/xon-200906-0006_Hereditarni_karcinom_prsu_Priklad_vzacnejsi_formy_karcinomu_prsu_v_populaci.php weekly 0.7 /artkey/xon-200906-0012_Autodidakticky_test_6_09.php weekly 0.7 /magno/xon/2008/mn1.php weekly 0.7 /artkey/xon-200801-0006_Casoprostorova_distribuce_vyvoje_karcinomu_kolorekta_v_CR.php weekly 0.7 /artkey/xon-200801-0007_Omezilo_zavadeni_tzv_cilene_lecby_vyznam_protinadorove_chemoterapie.php weekly 0.7 /artkey/xon-200801-0008_Prostaticky_specificky_antigen_PSA-situace_v_roce_2007.php weekly 0.7 /artkey/xon-200801-0009_Genetika_nadoru_prsu.php weekly 0.7 /artkey/xon-200801-0010_Novinky_v_lecbe_karcinomu_prsu.php weekly 0.7 /artkey/xon-200801-0001_Kolorektalni_karcinom-uvodem.php weekly 0.7 /artkey/xon-200801-0002_Diagnostika_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-200801-0003_Chirurgicka_lecba_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-200801-0004_Prehled_nechirurgicke_lecby_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-200801-0005_Dispenzarizace_nemocnych_po_radikalni_resekci_kolorektalniho_karcinomu.php weekly 0.7 /artkey/xon-200801-0011_Dosazeni_kompletni_remise_onemocneni_u_pacienta_s_generalizovanym_kolorektalnim_karcinomem_lecbou_i.php weekly 0.7 /artkey/xon-200801-0012_Pokrocily_karcinom_delozniho_hrdla-nova_indikace_topotekanu_Hycamtin_reg.php weekly 0.7 /magno/xon/2008/mn2.php weekly 0.7 /artkey/xon-200802-0008_Karcinom_ledviny-soucasne_trendy.php weekly 0.7 /artkey/xon-200802-0009_Lecba_karcinomu_pankreatu_ve_21_stoleti.php weekly 0.7 /artkey/xon-200802-0010_TRANSPLANTACE_KRVETVORNYCH_BUNEK-JEJI_VLIV_NA_SEXUALNI_FUNKCE_U_ZEN.php weekly 0.7 /artkey/xon-200802-0011_MOZNOSTI_MR_V_DIFERENCIALNEJ_DIAGNOSTIKE_PECENOVYCH_LEZII_2_cast.php weekly 0.7 /artkey/xon-200802-0012_ROLE_BRONCHOALVEOLARNI_LAVAZE_V_DIAGNOSTICE_PNEUMOPATII_V_DETSKE_ONKOLOGII.php weekly 0.7 /artkey/xon-200802-0013_Vyskyt_nadorovych_onemocneni_u_pacientu_po_transplantaci_srdce.php weekly 0.7 /artkey/xon-200802-0014_Erbitux_a_lecba_karcinomu_rekta.php weekly 0.7 /artkey/xon-200802-0001_Nadory_hlavy_a_krku-uvodem.php weekly 0.7 /artkey/xon-200802-0002_Soucasna_chirurgicka_lecba_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-200802-0003_Konformni_radioterapie_v_lecbe_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-200802-0004_Radioterapie_s_modulovanou_intenzitou_v_lecbe_karcinomu_hlavy_a_krku.php weekly 0.7 /artkey/xon-200802-0005_Kombinace_radioterapie_a_chemoterapie_v_lecbe_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-200802-0006_Nezadouci_ucinky_radioterapie_a_podpurna_lecba_u_radioterapie_nadoru_hlavy_a_krku.php weekly 0.7 /artkey/xon-200802-0007_Prehled_foniatrickych_moznosti_upravy_hlasu_po_onkologicke_lecbe_nadoru_oblasti_hlavy_a_krku.php weekly 0.7 /magno/xon/2008/mn3.php weekly 0.7 /artkey/xon-200803-0006_Akutni_lymfoblasticka_leukemie_dospivajicich_a_mladych_dospelych-identicka_biologicka_kategorie.php weekly 0.7 /artkey/xon-200803-0007_Syndrom_nadorove_anorexie_a_kachexie.php weekly 0.7 /artkey/xon-200803-0008_Lecebne_postupy_u_pokrocilych_testikularnich_germinalnich_nadoru.php weekly 0.7 /artkey/xon-200803-0009_TERAPIE_INVAZIVNICH_MYKOTICKYCH_INFEKCI_U_IMUNOSUPRIMOVANYCH_PACIENTU.php weekly 0.7 /artkey/xon-200803-0010_Autodidakticky_test_c_8201_3_2008.php weekly 0.7 /artkey/xon-200803-0011_SRDECNI_TRANSPLANTACE_U_PACIENTKY_S_MALIGNIM_TUMOREM_SRDCE.php weekly 0.7 /artkey/xon-200803-0012_Tamoxifen_a_QT_interval.php weekly 0.7 /artkey/xon-200803-0013_Karlstejn_2008_ceska_uroonkologie_a_svetovy_golf.php weekly 0.7 /artkey/xon-200803-0014_XXII_olomoucke_hematologicke_dny_s_mezinarodni_ucasti.php weekly 0.7 /artkey/xon-200803-0015_10th_International_Conference_on_Malignant_Lymphoma_cerven_2008_Lugano_Svycarsko.php weekly 0.7 /artkey/xon-200803-0001_Leukemie-uvodem.php weekly 0.7 /artkey/xon-200803-0002_Uziti_all-trans-retinove_kyseliny_u_akutni_promyelocytarni_leukemie-vice_nez_uspesny_model_cilene.php weekly 0.7 /artkey/xon-200803-0003_CHRONICKA_MYELOCYTOVA_LEUKEMIA-OD_MOLEKULOVEJ_PATOGENEZY_K_CIELENEJ_LIECBE.php weekly 0.7 /artkey/xon-200803-0004_Chronicka_lymfocytarni_leukemie.php weekly 0.7 /artkey/xon-200803-0005_Leukemie_s_vlasatymi_bunkami.php weekly 0.7 /artkey/xon-200803-0016_Predmet_povinne_mlcenlivosti_zdravotnickych_pracovniku.php weekly 0.7 /magno/xon/2008/mn4.php weekly 0.7 /artkey/xon-200804-0006_Soucasne_moznosti_laboratorniho_vysetrovani_pro_onkologicky_nemocne.php weekly 0.7 /artkey/xon-200804-0007_NADORY_CENTRALNIHO_NERVOVEHO_SYSTEMU_U_DETI_A_MLADISTVYCH.php weekly 0.7 /artkey/xon-200804-0008_RADIOTERAPIA_KARCINOMU_PROSTATY.php weekly 0.7 /artkey/xon-200804-0009_Podkozni_aplikace_leku_a_tekutin_v_paliativni_medicine.php weekly 0.7 /artkey/xon-200804-0010_Psychoterapie_v_onkologii.php weekly 0.7 /artkey/xon-200804-0013_Autodidakticky_test_c_8201_4_2008.php weekly 0.7 /artkey/xon-200804-0011_PRIMARNI_INTRAKRANIALNI_HODGKINUV_LYMFOM_U_12LETEHO_CHLAPCE.php weekly 0.7 /artkey/xon-200804-0012_UZLOVA_STRUMA_AKO_PRVY_PRIZNAK_NON-HODGKINOVHO_LYMFOMU_B-CLL_OD_OCHORENIA_STITNEJ_Z_AZY_K_OCHORENI.php weekly 0.7 /artkey/xon-200804-0014_XV_jihoceske_onkologicke_dny.php weekly 0.7 /artkey/xon-200804-0001_NADORY_JATER-uvodem.php weekly 0.7 /artkey/xon-200804-0002_Diagnostika_nadoru_jater.php weekly 0.7 /artkey/xon-200804-0003_Chirurgicka_lecba_nadoru_jater.php weekly 0.7 /artkey/xon-200804-0004_Onkologicka_lecba_nadoru_jater.php weekly 0.7 /artkey/xon-200804-0005_Nasledna_pece_u_nemocnych_s_metastatickym_postizenim_kolorektalniho_karcinomu_do_jater.php weekly 0.7 /magno/xon/2007/mn1.php weekly 0.7 /artkey/xon-200701-0001_Problematika_geriatrickej_onkologie_nastojcivo_vyzaduje_riesenie.php weekly 0.7 /artkey/xon-200701-0002_BLASTICKA_TRANSFORMACE_INDOLENTNICH_LYMFOMU.php weekly 0.7 /artkey/xon-200701-0003_CHEMOTERAPIA_HORMONALNE_REFRAKTERNEHO_KARCINOMU_PROSTATY.php weekly 0.7 /artkey/xon-200701-0004_MOZNOSTI_LIECBY_MNOHOPOCETNEHO_MYELOMU.php weekly 0.7 /artkey/xon-200701-0005_BIOLOGICKA_LIECBA_NEMALOBUNKOVEHO_P_UCNEHO_KARCINOMU.php weekly 0.7 /artkey/xon-200701-0006_MINIMALNE_INVAZIVNE_TECHNIKY_V_LIECBE_VCASNYCH_NADOROV_KOLOREKTA.php weekly 0.7 /artkey/xon-200701-0007_RADIOTERAPIA_V_LIECBE_NADOROV_Z_NEZNAMEHO_PRIMARNEHO_LOZISKA.php weekly 0.7 /artkey/xon-200701-0008_NADORY_P_UC_V_STARSOM_VEKU.php weekly 0.7 /artkey/xon-200701-0009_ZPRAVA_O_DNECH_DIAGNOSTICKE_PREDIKTIVNI_A_EXPERIMENTALNI_ONKOLOGIE.php weekly 0.7 /artkey/xon-200701-0010_VIII_NITRIANSKE_DNI_NUKLEARNEJ_MEDICINY_23_-24_NOVEMBER_2006.php weekly 0.7 /artkey/xon-200701-0011_SPRAVA_Z_X_KOSICKYCH_CHEMOTERAPEUTICKYCH_DNI_23_8722_24_NOVEMBER_2006.php weekly 0.7 /artkey/xon-200701-0012_Ze_zahranicniho_tisku.php weekly 0.7 /artkey/xon-200701-0013_Exemestan_zlepsuje_vysledky_adjuvantni_lecby_hormon-dependentniho_karcinomu_mlecne_zlazy_u_postmeno.php weekly 0.7 /artkey/xon-200701-0014_Test_c_1_2007.php weekly 0.7 /magno/xon/2007/mn2.php weekly 0.7 /artkey/xon-200702-0001_Vyjadreni_Ceske_onkologicke_spolecnosti_CLS_JEP_ke_zkreslenym_informacim_o_preziti_onkologicky_nemo.php weekly 0.7 /artkey/xon-200702-0002_Rakovina_zaludka.php weekly 0.7 /artkey/xon-200702-0003_Chemoterapia_nadorov_hlavy_a_krku.php weekly 0.7 /artkey/xon-200702-0004_Pokroky_v_liecbe_gastrointestinalnych_stromalnych_tumorov.php weekly 0.7 /artkey/xon-200702-0005_Maligne_tumory_srdca.php weekly 0.7 /artkey/xon-200702-0006_Zobrazenie_gastrointestinalneho_stromalneho_tumoru_s_18FDG_fluorodeoxyglukozou_metodou_pozitronov.php weekly 0.7 /artkey/xon-200702-0007_Biopticka_diagnostika_gastrointestinalnych_stromalnych_nadorov.php weekly 0.7 /artkey/xon-200702-0008_Moznosti_mr_v_diferencialnej_diagnostike_pecenovych_lezii_1_cast.php weekly 0.7 /artkey/xon-200702-0010_XXI_Olomoucke_hematologicke_dny_s_mezinarodni_ucasti_16_-19_6_2007.php weekly 0.7 /artkey/xon-200702-0011_Autodidakticky_test.php weekly 0.7 /artkey/xon-200702-0009_Sunitinib_je_ucinny_v_lecbe_pokrocileho_karcinomu_ledvin.php weekly 0.7 /magindex.php daily 0.7